Left Ventricular Function Recovery After Coronary Revascularization and Medical Therapy: A Systematic Review and Meta-Analysis

Left Ventricular Function Recovery After Coronary... | F1000Research "use strict";function _typeof(t){return(_typeof="function"==typeof Symbol&&"symbol"==typeof Symbol.iterator?function(t){return typeof t}:function(t){return t&&"function"==typeof Symbol&&t.constructor===Symbol&&t!==Symbol.prototype?"symbol":typeof t})(t)}!function(){var t=function(){var t,e,o=[],n=window,r=n;for(;r;){try{if(r.frames.__tcfapiLocator){t=r;break}}catch(t){}if(r===n.top)break;r=r.parent}t||(!function t(){var e=n.document,o=!!n.frames.__tcfapiLocator;if(!o)if(e.body){var r=e.createElement("iframe");r.style.cssText="display:none",r.name="__tcfapiLocator",e.body.appendChild(r)}else setTimeout(t,5);return!o}(),n.__tcfapi=function(){for(var t=arguments.length,n=new Array(t),r=0;r 3&&2===parseInt(n[1],10)&&"boolean"==typeof n[3]&&(e=n[3],"function"==typeof n[2]&&n[2]("set",!0)):"ping"===n[0]?"function"==typeof n[2]&&n[2]({gdprApplies:e,cmpLoaded:!1,cmpStatus:"stub"}):o.push(n)},n.addEventListener("message",(function(t){var e="string"==typeof t.data,o={};if(e)try{o=JSON.parse(t.data)}catch(t){}else o=t.data;var n="object"===_typeof(o)&&null!==o?o.__tcfapiCall:null;n&&window.__tcfapi(n.command,n.version,(function(o,r){var a={__tcfapiReturn:{returnValue:o,success:r,callId:n.callId}};t&&t.source&&t.source.postMessage&&t.source.postMessage(e?JSON.stringify(a):a,"*")}),n.parameter)}),!1))};"undefined"!=typeof module?module.exports=t:t()}(); dataLayer = dataLayer || []; // Standard GTM initialization - Google Consent Mode handles consent automatically (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start': new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0], j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src= 'https://www.googletagmanager.com/gtm.js?id='+i+dl+ '>m_auth=hzk0Vc3qFsQYhCrIoHz68A>m_preview=env-1>m_cookies_win=x';f.parentNode.insertBefore(j,f); })(window,document,'script','dataLayer','GTM-MWFK8L5J'); ;window.NREUM||(NREUM={});NREUM.init={distributed_tracing:{enabled:true},privacy:{cookies_enabled:true},ajax:{deny_list:["bam.nr-data.net"]}}; ;NREUM.loader_config={accountID:"438030",trustKey:"438030",agentID:"772317073",licenseKey:"97f8f67f26",applicationID:"772317073"} ;NREUM.info={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net",licenseKey:"97f8f67f26",applicationID:"772317073",sa:1} ;/*! For license information please see nr-loader-spa-1.236.0.min.js.LICENSE.txt */ (()=>{"use strict";var e,t,r={5763:(e,t,r)=>{r.d(t,{P_:()=>l,Mt:()=>g,C5:()=>s,DL:()=>v,OP:()=>T,lF:()=>D,Yu:()=>y,Dg:()=>h,CX:()=>c,GE:()=>b,sU:()=>_});var n=r(8632),i=r(9567);const o={beacon:n.ce.beacon,errorBeacon:n.ce.errorBeacon,licenseKey:void 0,applicationID:void 0,sa:void 0,queueTime:void 0,applicationTime:void 0,ttGuid:void 0,user:void 0,account:void 0,product:void 0,extra:void 0,jsAttributes:{},userAttributes:void 0,atts:void 0,transactionName:void 0,tNamePlain:void 0},a={};function s(e){if(!e)throw new Error("All info objects require an agent identifier!");if(!a[e])throw new Error("Info for ".concat(e," was never set"));return a[e]}function c(e,t){if(!e)throw new Error("All info objects require an agent identifier!");a[e]=(0,i.D)(t,o),(0,n.Qy)(e,a[e],"info")}var u=r(7056);const d=()=>{const e={blockSelector:"[data-nr-block]",maskInputOptions:{password:!0}};return{allow_bfcache:!0,privacy:{cookies_enabled:!0},ajax:{deny_list:void 0,enabled:!0,harvestTimeSeconds:10},distributed_tracing:{enabled:void 0,exclude_newrelic_header:void 0,cors_use_newrelic_header:void 0,cors_use_tracecontext_headers:void 0,allowed_origins:void 0},session:{domain:void 0,expiresMs:u.oD,inactiveMs:u.Hb},ssl:void 0,obfuscate:void 0,jserrors:{enabled:!0,harvestTimeSeconds:10},metrics:{enabled:!0},page_action:{enabled:!0,harvestTimeSeconds:30},page_view_event:{enabled:!0},page_view_timing:{enabled:!0,harvestTimeSeconds:30,long_task:!1},session_trace:{enabled:!0,harvestTimeSeconds:10},harvest:{tooManyRequestsDelay:60},session_replay:{enabled:!1,harvestTimeSeconds:60,sampleRate:.1,errorSampleRate:.1,maskTextSelector:"*",maskAllInputs:!0,get blockClass(){return"nr-block"},get ignoreClass(){return"nr-ignore"},get maskTextClass(){return"nr-mask"},get blockSelector(){return e.blockSelector},set blockSelector(t){e.blockSelector+=",".concat(t)},get maskInputOptions(){return e.maskInputOptions},set maskInputOptions(t){e.maskInputOptions={...t,password:!0}}},spa:{enabled:!0,harvestTimeSeconds:10}}},f={};function l(e){if(!e)throw new Error("All configuration objects require an agent identifier!");if(!f[e])throw new Error("Configuration for ".concat(e," was never set"));return f[e]}function h(e,t){if(!e)throw new Error("All configuration objects require an agent identifier!");f[e]=(0,i.D)(t,d()),(0,n.Qy)(e,f[e],"config")}function g(e,t){if(!e)throw new Error("All configuration objects require an agent identifier!");var r=l(e);if(r){for(var n=t.split("."),i=0;i {r.d(t,{D:()=>i});var n=r(50);function i(e,t){try{if(!e||"object"!=typeof e)return(0,n.Z)("Setting a Configurable requires an object as input");if(!t||"object"!=typeof t)return(0,n.Z)("Setting a Configurable requires a model to set its initial properties");const r=Object.create(Object.getPrototypeOf(t),Object.getOwnPropertyDescriptors(t)),o=0===Object.keys(r).length?e:r;for(let a in o)if(void 0!==e[a])try{"object"==typeof e[a]&&"object"==typeof t[a]?r[a]=i(e[a],t[a]):r[a]=e[a]}catch(e){(0,n.Z)("An error occurred while setting a property of a Configurable",e)}return r}catch(e){(0,n.Z)("An error occured while setting a Configurable",e)}}},6818:(e,t,r)=>{r.d(t,{Re:()=>i,gF:()=>o,q4:()=>n});const n="1.236.0",i="PROD",o="CDN"},385:(e,t,r)=>{r.d(t,{FN:()=>a,IF:()=>u,Nk:()=>f,Tt:()=>s,_A:()=>o,il:()=>n,pL:()=>c,v6:()=>i,w1:()=>d});const n="undefined"!=typeof window&&!!window.document,i="undefined"!=typeof WorkerGlobalScope&&("undefined"!=typeof self&&self instanceof WorkerGlobalScope&&self.navigator instanceof WorkerNavigator||"undefined"!=typeof globalThis&&globalThis instanceof WorkerGlobalScope&&globalThis.navigator instanceof WorkerNavigator),o=n?window:"undefined"!=typeof WorkerGlobalScope&&("undefined"!=typeof self&&self instanceof WorkerGlobalScope&&self||"undefined"!=typeof globalThis&&globalThis instanceof WorkerGlobalScope&&globalThis),a=""+o?.location,s=/iPad|iPhone|iPod/.test(navigator.userAgent),c=s&&"undefined"==typeof SharedWorker,u=(()=>{const e=navigator.userAgent.match(/Firefox[/\s](\d+\.\d+)/);return Array.isArray(e)&&e.length>=2?+e[1]:0})(),d=Boolean(n&&window.document.documentMode),f=!!navigator.sendBeacon},1117:(e,t,r)=>{r.d(t,{w:()=>o});var n=r(50);const i={agentIdentifier:"",ee:void 0};class o{constructor(e){try{if("object"!=typeof e)return(0,n.Z)("shared context requires an object as input");this.sharedContext={},Object.assign(this.sharedContext,i),Object.entries(e).forEach((e=>{let[t,r]=e;Object.keys(i).includes(t)&&(this.sharedContext[t]=r)}))}catch(e){(0,n.Z)("An error occured while setting SharedContext",e)}}}},8e3:(e,t,r)=>{r.d(t,{L:()=>d,R:()=>c});var n=r(2177),i=r(1284),o=r(4322),a=r(3325);const s={};function c(e,t){const r={staged:!1,priority:a.p[t]||0};u(e),s[e].get(t)||s[e].set(t,r)}function u(e){e&&(s[e]||(s[e]=new Map))}function d(){let e=arguments.length>0&&void 0!==arguments[0]?arguments[0]:"",t=arguments.length>1&&void 0!==arguments[1]?arguments[1]:"feature";if(u(e),!e||!s[e].get(t))return a(t);s[e].get(t).staged=!0;const r=[...s[e]];function a(t){const r=e?n.ee.get(e):n.ee,a=o.X.handlers;if(r.backlog&&a){var s=r.backlog[t],c=a[t];if(c){for(var u=0;s&&u {let[t,r]=e;return r.staged}))&&(r.sort(((e,t)=>e[1].priority-t[1].priority)),r.forEach((e=>{let[t]=e;a(t)})))}function f(e,t){var r=e[1];(0,i.D)(t[r],(function(t,r){var n=e[0];if(r[0]===n){var i=r[1],o=e[3],a=e[2];i.apply(o,a)}}))}},2177:(e,t,r)=>{r.d(t,{c:()=>f,ee:()=>u});var n=r(8632),i=r(2210),o=r(1284),a=r(5763),s="nr@context";let c=(0,n.fP)();var u;function d(){}function f(e){return(0,i.X)(e,s,l)}function l(){return new d}function h(){u.aborted=!0,u.backlog={}}c.ee?u=c.ee:(u=function e(t,r){var n={},c={},f={},g=!1;try{g=16===r.length&&(0,a.OP)(r).isolatedBacklog}catch(e){}var p={on:b,addEventListener:b,removeEventListener:y,emit:v,get:x,listeners:w,context:m,buffer:A,abort:h,aborted:!1,isBuffering:E,debugId:r,backlog:g?{}:t&&"object"==typeof t.backlog?t.backlog:{}};return p;function m(e){return e&&e instanceof d?e:e?(0,i.X)(e,s,l):l()}function v(e,r,n,i,o){if(!1!==o&&(o=!0),!u.aborted||i){t&&o&&t.emit(e,r,n);for(var a=m(n),s=w(e),d=s.length,f=0;fn,p:()=>i});var n=r(2177).ee.get("handle");function i(e,t,r,i,o){o?(o.buffer([e],i),o.emit(e,t,r)):(n.buffer([e],i),n.emit(e,t,r))}},4322:(e,t,r)=>{r.d(t,{X:()=>o});var n=r(5546);o.on=a;var i=o.handlers={};function o(e,t,r,o){a(o||n.E,i,e,t,r)}function a(e,t,r,i,o){o||(o="feature"),e||(e=n.E);var a=t[o]=t[o]||{};(a[r]=a[r]||[]).push([e,i])}},3239:(e,t,r)=>{r.d(t,{bP:()=>s,iz:()=>c,m$:()=>a});var n=r(385);let i=!1,o=!1;try{const e={get passive(){return i=!0,!1},get signal(){return o=!0,!1}};n._A.addEventListener("test",null,e),n._A.removeEventListener("test",null,e)}catch(e){}function a(e,t){return i||o?{capture:!!e,passive:i,signal:t}:!!e}function s(e,t){let r=arguments.length>2&&void 0!==arguments[2]&&arguments[2],n=arguments.length>3?arguments[3]:void 0;window.addEventListener(e,t,a(r,n))}function c(e,t){let r=arguments.length>2&&void 0!==arguments[2]&&arguments[2],n=arguments.length>3?arguments[3]:void 0;document.addEventListener(e,t,a(r,n))}},4402:(e,t,r)=>{r.d(t,{Ht:()=>u,M:()=>c,Rl:()=>a,ky:()=>s});var n=r(385);const i="xxxxxxxx-xxxx-4xxx-yxxx-xxxxxxxxxxxx";function o(e,t){return e?15&e[t]:16*Math.random()|0}function a(){const e=n._A?.crypto||n._A?.msCrypto;let t,r=0;return e&&e.getRandomValues&&(t=e.getRandomValues(new Uint8Array(31))),i.split("").map((e=>"x"===e?o(t,++r).toString(16):"y"===e?(3&o()|8).toString(16):e)).join("")}function s(e){const t=n._A?.crypto||n._A?.msCrypto;let r,i=0;t&&t.getRandomValues&&(r=t.getRandomValues(new Uint8Array(31)));const a=[];for(var s=0;s {r.d(t,{Bq:()=>n,Hb:()=>o,oD:()=>i});const n="NRBA",i=144e5,o=18e5},7894:(e,t,r)=>{function n(){return Math.round(performance.now())}r.d(t,{z:()=>n})},7243:(e,t,r)=>{r.d(t,{e:()=>o});var n=r(385),i={};function o(e){if(e in i)return i[e];if(0===(e||"").indexOf("data:"))return{protocol:"data"};let t;var r=n._A?.location,o={};if(n.il)t=document.createElement("a"),t.href=e;else try{t=new URL(e,r.href)}catch(e){return o}o.port=t.port;var a=t.href.split("://");!o.port&&a[1]&&(o.port=a[1].split("/")[0].split("@").pop().split(":")[1]),o.port&&"0"!==o.port||(o.port="https"===a[0]?"443":"80"),o.hostname=t.hostname||r.hostname,o.pathname=t.pathname,o.protocol=a[0],"/"!==o.pathname.charAt(0)&&(o.pathname="/"+o.pathname);var s=!t.protocol||":"===t.protocol||t.protocol===r.protocol,c=t.hostname===r.hostname&&t.port===r.port;return o.sameOrigin=s&&(!t.hostname||c),"/"===o.pathname&&(i[e]=o),o}},50:(e,t,r)=>{function n(e,t){"function"==typeof console.warn&&(console.warn("New Relic: ".concat(e)),t&&console.warn(t))}r.d(t,{Z:()=>n})},2587:(e,t,r)=>{r.d(t,{N:()=>c,T:()=>u});var n=r(2177),i=r(5546),o=r(8e3),a=r(3325);const s={stn:[a.D.sessionTrace],err:[a.D.jserrors,a.D.metrics],ins:[a.D.pageAction],spa:[a.D.spa],sr:[a.D.sessionReplay,a.D.sessionTrace]};function c(e,t){const r=n.ee.get(t);e&&"object"==typeof e&&(Object.entries(e).forEach((e=>{let[t,n]=e;void 0===u[t]&&(s[t]?s[t].forEach((e=>{n?(0,i.p)("feat-"+t,[],void 0,e,r):(0,i.p)("block-"+t,[],void 0,e,r),(0,i.p)("rumresp-"+t,[Boolean(n)],void 0,e,r)})):n&&(0,i.p)("feat-"+t,[],void 0,void 0,r),u[t]=Boolean(n))})),Object.keys(s).forEach((e=>{void 0===u[e]&&(s[e]?.forEach((t=>(0,i.p)("rumresp-"+e,[!1],void 0,t,r))),u[e]=!1)})),(0,o.L)(t,a.D.pageViewEvent))}const u={}},2210:(e,t,r)=>{r.d(t,{X:()=>i});var n=Object.prototype.hasOwnProperty;function i(e,t,r){if(n.call(e,t))return e[t];var i=r();if(Object.defineProperty&&Object.keys)try{return Object.defineProperty(e,t,{value:i,writable:!0,enumerable:!1}),i}catch(e){}return e[t]=i,i}},1284:(e,t,r)=>{r.d(t,{D:()=>n});const n=(e,t)=>Object.entries(e||{}).map((e=>{let[r,n]=e;return t(r,n)}))},4351:(e,t,r)=>{r.d(t,{P:()=>o});var n=r(2177);const i=()=>{const e=new WeakSet;return(t,r)=>{if("object"==typeof r&&null!==r){if(e.has(r))return;e.add(r)}return r}};function o(e){try{return JSON.stringify(e,i())}catch(e){try{n.ee.emit("internal-error",[e])}catch(e){}}}},3960:(e,t,r)=>{r.d(t,{K:()=>a,b:()=>o});var n=r(3239);function i(){return"undefined"==typeof document||"complete"===document.readyState}function o(e,t){if(i())return e();(0,n.bP)("load",e,t)}function a(e){if(i())return e();(0,n.iz)("DOMContentLoaded",e)}},8632:(e,t,r)=>{r.d(t,{EZ:()=>u,Qy:()=>c,ce:()=>o,fP:()=>a,gG:()=>d,mF:()=>s});var n=r(7894),i=r(385);const o={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net"};function a(){return i._A.NREUM||(i._A.NREUM={}),void 0===i._A.newrelic&&(i._A.newrelic=i._A.NREUM),i._A.NREUM}function s(){let e=a();return e.o||(e.o={ST:i._A.setTimeout,SI:i._A.setImmediate,CT:i._A.clearTimeout,XHR:i._A.XMLHttpRequest,REQ:i._A.Request,EV:i._A.Event,PR:i._A.Promise,MO:i._A.MutationObserver,FETCH:i._A.fetch}),e}function c(e,t,r){let i=a();const o=i.initializedAgents||{},s=o[e]||{};return Object.keys(s).length||(s.initializedAt={ms:(0,n.z)(),date:new Date}),i.initializedAgents={...o,[e]:{...s,[r]:t}},i}function u(e,t){a()[e]=t}function d(){return function(){let e=a();const t=e.info||{};e.info={beacon:o.beacon,errorBeacon:o.errorBeacon,...t}}(),function(){let e=a();const t=e.init||{};e.init={...t}}(),s(),function(){let e=a();const t=e.loader_config||{};e.loader_config={...t}}(),a()}},7956:(e,t,r)=>{r.d(t,{N:()=>i});var n=r(3239);function i(e){let t=arguments.length>1&&void 0!==arguments[1]&&arguments[1],r=arguments.length>2?arguments[2]:void 0,i=arguments.length>3?arguments[3]:void 0;return void(0,n.iz)("visibilitychange",(function(){if(t)return void("hidden"==document.visibilityState&&e());e(document.visibilityState)}),r,i)}},1214:(e,t,r)=>{r.d(t,{em:()=>v,u5:()=>N,QU:()=>S,_L:()=>I,Gm:()=>L,Lg:()=>M,gy:()=>U,BV:()=>Q,Kf:()=>ee});var n=r(2177);const i="nr@original";var o=Object.prototype.hasOwnProperty,a=!1;function s(e,t){return e||(e=n.ee),r.inPlace=function(e,t,n,i,o){n||(n="");var a,s,c,u="-"===n.charAt(0);for(c=0;c 2?n-2:0),o=2;o {r(A[T],e,w),r(E[T],e,w)})),r(l._A,"fetch",y),t.on(y+"end",(function(e,r){var n=this;if(r){var i=r.headers.get("content-length");null!==i&&(n.rxSize=i),t.emit(y+"done",[null,r],n)}else t.emit(y+"done",[e],n)})),t}const O={},j=["pushState","replaceState"];function S(e){const t=function(e){return(e||n.ee).get("history")}(e);return!l.il||O[t.debugId]++||(O[t.debugId]=1,s(t).inPlace(window.history,j,"-")),t}var P=r(3239);const C={},R=["appendChild","insertBefore","replaceChild"];function I(e){const t=function(e){return(e||n.ee).get("jsonp")}(e);if(!l.il||C[t.debugId])return t;C[t.debugId]=!0;var r=s(t),i=/[?&](?:callback|cb)=([^&#]+)/,o=/(.*)\.([^.]+)/,a=/^(\w+)(\.|$)(.*)$/;function c(e,t){var r=e.match(a),n=r[1],i=r[3];return i?c(i,t[n]):t[n]}return r.inPlace(Node.prototype,R,"dom-"),t.on("dom-start",(function(e){!function(e){if(!e||"string"!=typeof e.nodeName||"script"!==e.nodeName.toLowerCase())return;if("function"!=typeof e.addEventListener)return;var n=(a=e.src,s=a.match(i),s?s[1]:null);var a,s;if(!n)return;var u=function(e){var t=e.match(o);if(t&&t.length>=3)return{key:t[2],parent:c(t[1],window)};return{key:e,parent:window}}(n);if("function"!=typeof u.parent[u.key])return;var d={};function f(){t.emit("jsonp-end",[],d),e.removeEventListener("load",f,(0,P.m$)(!1)),e.removeEventListener("error",l,(0,P.m$)(!1))}function l(){t.emit("jsonp-error",[],d),t.emit("jsonp-end",[],d),e.removeEventListener("load",f,(0,P.m$)(!1)),e.removeEventListener("error",l,(0,P.m$)(!1))}r.inPlace(u.parent,[u.key],"cb-",d),e.addEventListener("load",f,(0,P.m$)(!1)),e.addEventListener("error",l,(0,P.m$)(!1)),t.emit("new-jsonp",[e.src],d)}(e[0])})),t}var k=r(5763);const H={};function L(e){const t=function(e){return(e||n.ee).get("mutation")}(e);if(!l.il||H[t.debugId])return t;H[t.debugId]=!0;var r=s(t),i=k.Yu.MO;return i&&(window.MutationObserver=function(e){return this instanceof i?new i(r(e,"fn-")):i.apply(this,arguments)},MutationObserver.prototype=i.prototype),t}const z={};function M(e){const t=function(e){return(e||n.ee).get("promise")}(e);if(z[t.debugId])return t;z[t.debugId]=!0;var r=n.c,o=s(t),a=k.Yu.PR;return a&&function(){function e(r){var n=t.context(),i=o(r,"executor-",n,null,!1);const s=Reflect.construct(a,[i],e);return t.context(s).getCtx=function(){return n},s}l._A.Promise=e,Object.defineProperty(e,"name",{value:"Promise"}),e.toString=function(){return a.toString()},Object.setPrototypeOf(e,a),["all","race"].forEach((function(r){const n=a[r];e[r]=function(e){let i=!1;[...e||[]].forEach((e=>{this.resolve(e).then(a("all"===r),a(!1))}));const o=n.apply(this,arguments);return o;function a(e){return function(){t.emit("propagate",[null,!i],o,!1,!1),i=i||!e}}}})),["resolve","reject"].forEach((function(r){const n=a[r];e[r]=function(e){const r=n.apply(this,arguments);return e!==r&&t.emit("propagate",[e,!0],r,!1,!1),r}})),e.prototype=a.prototype;const n=a.prototype.then;a.prototype.then=function(){var e=this,i=r(e);i.promise=e;for(var a=arguments.length,s=new Array(a),c=0;c e())),t};function m(e,t){i.inPlace(t,["onreadystatechange"],"fn-",E)}function b(){var e=this,t=r.context(e);e.readyState>3&&!t.resolved&&(t.resolved=!0,r.emit("xhr-resolved",[],e)),i.inPlace(e,f,"fn-",E)}if(function(e,t){for(var r in e)t[r]=e[r]}(o,p),p.prototype=o.prototype,i.inPlace(p.prototype,J,"-xhr-",E),r.on("send-xhr-start",(function(e,t){m(e,t),function(e){h.push(e),a&&(y?y.then(A):u?u(A):(w=-w,x.data=w))}(t)})),r.on("open-xhr-start",m),a){var y=c&&c.resolve();if(!u&&!c){var w=1,x=document.createTextNode(w);new a(A).observe(x,{characterData:!0})}}else t.on("fn-end",(function(e){e[0]&&e[0].type===d||A()}));function A(){for(var e=0;e {r.d(t,{t:()=>n});const n=r(3325).D.ajax},6660:(e,t,r)=>{r.d(t,{A:()=>i,t:()=>n});const n=r(3325).D.jserrors,i="nr@seenError"},3081:(e,t,r)=>{r.d(t,{gF:()=>o,mY:()=>i,t9:()=>n,vz:()=>s,xS:()=>a});const n=r(3325).D.metrics,i="sm",o="cm",a="storeSupportabilityMetrics",s="storeEventMetrics"},4649:(e,t,r)=>{r.d(t,{t:()=>n});const n=r(3325).D.pageAction},7633:(e,t,r)=>{r.d(t,{Dz:()=>i,OJ:()=>a,qw:()=>o,t9:()=>n});const n=r(3325).D.pageViewEvent,i="firstbyte",o="domcontent",a="windowload"},9251:(e,t,r)=>{r.d(t,{t:()=>n});const n=r(3325).D.pageViewTiming},3614:(e,t,r)=>{r.d(t,{BST_RESOURCE:()=>i,END:()=>s,FEATURE_NAME:()=>n,FN_END:()=>u,FN_START:()=>c,PUSH_STATE:()=>d,RESOURCE:()=>o,START:()=>a});const n=r(3325).D.sessionTrace,i="bstResource",o="resource",a="-start",s="-end",c="fn"+a,u="fn"+s,d="pushState"},7836:(e,t,r)=>{r.d(t,{BODY:()=>A,CB_END:()=>E,CB_START:()=>u,END:()=>x,FEATURE_NAME:()=>i,FETCH:()=>_,FETCH_BODY:()=>v,FETCH_DONE:()=>m,FETCH_START:()=>p,FN_END:()=>c,FN_START:()=>s,INTERACTION:()=>l,INTERACTION_API:()=>d,INTERACTION_EVENTS:()=>o,JSONP_END:()=>b,JSONP_NODE:()=>g,JS_TIME:()=>T,MAX_TIMER_BUDGET:()=>a,REMAINING:()=>f,SPA_NODE:()=>h,START:()=>w,originalSetTimeout:()=>y});var n=r(5763);const i=r(3325).D.spa,o=["click","submit","keypress","keydown","keyup","change"],a=999,s="fn-start",c="fn-end",u="cb-start",d="api-ixn-",f="remaining",l="interaction",h="spaNode",g="jsonpNode",p="fetch-start",m="fetch-done",v="fetch-body-",b="jsonp-end",y=n.Yu.ST,w="-start",x="-end",A="-body",E="cb"+x,T="jsTime",_="fetch"},5938:(e,t,r)=>{r.d(t,{W:()=>o});var n=r(5763),i=r(2177);class o{constructor(e,t,r){this.agentIdentifier=e,this.aggregator=t,this.ee=i.ee.get(e,(0,n.OP)(this.agentIdentifier).isolatedBacklog),this.featureName=r,this.blocked=!1}}},9144:(e,t,r)=>{r.d(t,{j:()=>m});var n=r(3325),i=r(5763),o=r(5546),a=r(2177),s=r(7894),c=r(8e3),u=r(3960),d=r(385),f=r(50),l=r(3081),h=r(8632);function g(){const e=(0,h.gG)();["setErrorHandler","finished","addToTrace","inlineHit","addRelease","addPageAction","setCurrentRouteName","setPageViewName","setCustomAttribute","interaction","noticeError","setUserId"].forEach((t=>{e[t]=function(){for(var r=arguments.length,n=new Array(r),i=0;i 1?r-1:0),i=1;i {e.exposed&&e.api[t]&&o.push(e.api[t](...n))})),o.length>1?o:o[0]}(t,...n)}}))}var p=r(2587);function m(e){let t=arguments.length>1&&void 0!==arguments[1]?arguments[1]:{},m=arguments.length>2?arguments[2]:void 0,v=arguments.length>3?arguments[3]:void 0,{init:b,info:y,loader_config:w,runtime:x={loaderType:m},exposed:A=!0}=t;const E=(0,h.gG)();y||(b=E.init,y=E.info,w=E.loader_config),(0,i.Dg)(e,b||{}),(0,i.GE)(e,w||{}),(0,i.sU)(e,x),y.jsAttributes??={},d.v6&&(y.jsAttributes.isWorker=!0),(0,i.CX)(e,y),g();const T=function(e,t){t||(0,c.R)(e,"api");const h={};var g=a.ee.get(e),p=g.get("tracer"),m="api-",v=m+"ixn-";function b(t,r,n,o){const a=(0,i.C5)(e);return null===r?delete a.jsAttributes[t]:(0,i.CX)(e,{...a,jsAttributes:{...a.jsAttributes,[t]:r}}),x(m,n,!0,o||null===r?"session":void 0)(t,r)}function y(){}["setErrorHandler","finished","addToTrace","inlineHit","addRelease"].forEach((e=>h[e]=x(m,e,!0,"api"))),h.addPageAction=x(m,"addPageAction",!0,n.D.pageAction),h.setCurrentRouteName=x(m,"routeName",!0,n.D.spa),h.setPageViewName=function(t,r){if("string"==typeof t)return"/"!==t.charAt(0)&&(t="/"+t),(0,i.OP)(e).customTransaction=(r||"http://custom.transaction")+t,x(m,"setPageViewName",!0)()},h.setCustomAttribute=function(e,t){let r=arguments.length>2&&void 0!==arguments[2]&&arguments[2];if("string"==typeof e){if(["string","number"].includes(typeof t)||null===t)return b(e,t,"setCustomAttribute",r);(0,f.Z)("Failed to execute setCustomAttribute.\nNon-null value must be a string or number type, but a type of was provided."))}else(0,f.Z)("Failed to execute setCustomAttribute.\nName must be a string type, but a type of was provided."))},h.setUserId=function(e){if("string"==typeof e||null===e)return b("enduser.id",e,"setUserId",!0);(0,f.Z)("Failed to execute setUserId.\nNon-null value must be a string type, but a type of was provided."))},h.interaction=function(){return(new y).get()};var w=y.prototype={createTracer:function(e,t){var r={},i=this,a="function"==typeof t;return(0,o.p)(v+"tracer",[(0,s.z)(),e,r],i,n.D.spa,g),function(){if(p.emit((a?"":"no-")+"fn-start",[(0,s.z)(),i,a],r),a)try{return t.apply(this,arguments)}catch(e){throw p.emit("fn-err",[arguments,this,"string"==typeof e?new Error(e):e],r),e}finally{p.emit("fn-end",[(0,s.z)()],r)}}}};function x(e,t,r,i){return function(){return(0,o.p)(l.xS,["API/"+t+"/called"],void 0,n.D.metrics,g),i&&(0,o.p)(e+t,[(0,s.z)(),...arguments],r?null:this,i,g),r?void 0:this}}function A(){r.e(439).then(r.bind(r,7438)).then((t=>{let{setAPI:r}=t;r(e),(0,c.L)(e,"api")})).catch((()=>(0,f.Z)("Downloading runtime APIs failed...")))}return["actionText","setName","setAttribute","save","ignore","onEnd","getContext","end","get"].forEach((e=>{w[e]=x(v,e,void 0,n.D.spa)})),h.noticeError=function(e,t){"string"==typeof e&&(e=new Error(e)),(0,o.p)(l.xS,["API/noticeError/called"],void 0,n.D.metrics,g),(0,o.p)("err",[e,(0,s.z)(),!1,t],void 0,n.D.jserrors,g)},d.il?(0,u.b)((()=>A()),!0):A(),h}(e,v);return(0,h.Qy)(e,T,"api"),(0,h.Qy)(e,A,"exposed"),(0,h.EZ)("activatedFeatures",p.T),T}},3325:(e,t,r)=>{r.d(t,{D:()=>n,p:()=>i});const n={ajax:"ajax",jserrors:"jserrors",metrics:"metrics",pageAction:"page_action",pageViewEvent:"page_view_event",pageViewTiming:"page_view_timing",sessionReplay:"session_replay",sessionTrace:"session_trace",spa:"spa"},i={[n.pageViewEvent]:1,[n.pageViewTiming]:2,[n.metrics]:3,[n.jserrors]:4,[n.ajax]:5,[n.sessionTrace]:6,[n.pageAction]:7,[n.spa]:8,[n.sessionReplay]:9}}},n={};function i(e){var t=n[e];if(void 0!==t)return t.exports;var o=n[e]={exports:{}};return r[e](o,o.exports,i),o.exports}i.m=r,i.d=(e,t)=>{for(var r in t)i.o(t,r)&&!i.o(e,r)&&Object.defineProperty(e,r,{enumerable:!0,get:t[r]})},i.f={},i.e=e=>Promise.all(Object.keys(i.f).reduce(((t,r)=>(i.f[r](e,t),t)),[])),i.u=e=>(({78:"page_action-aggregate",147:"metrics-aggregate",242:"session-manager",317:"jserrors-aggregate",348:"page_view_timing-aggregate",412:"lazy-feature-loader",439:"async-api",538:"recorder",590:"session_replay-aggregate",675:"compressor",733:"session_trace-aggregate",786:"page_view_event-aggregate",873:"spa-aggregate",898:"ajax-aggregate"}[e]||e)+"."+{78:"ac76d497",147:"3dc53903",148:"1a20d5fe",242:"2a64278a",317:"49e41428",348:"bd6de33a",412:"2f55ce66",439:"30bd804e",538:"1b18459f",590:"cf0efb30",675:"ae9f91a8",733:"83105561",786:"06482edd",860:"03a8b7a5",873:"e6b09d52",898:"998ef92b"}[e]+"-1.236.0.min.js"),i.o=(e,t)=>Object.prototype.hasOwnProperty.call(e,t),e={},t="NRBA:",i.l=(r,n,o,a)=>{if(e[r])e[r].push(n);else{var s,c;if(void 0!==o)for(var u=document.getElementsByTagName("script"),d=0;d {s.onerror=s.onload=null,clearTimeout(h);var i=e[r];if(delete e[r],s.parentNode&&s.parentNode.removeChild(s),i&&i.forEach((e=>e(n))),t)return t(n)},h=setTimeout(l.bind(null,void 0,{type:"timeout",target:s}),12e4);s.onerror=l.bind(null,s.onerror),s.onload=l.bind(null,s.onload),c&&document.head.appendChild(s)}},i.r=e=>{"undefined"!=typeof Symbol&&Symbol.toStringTag&&Object.defineProperty(e,Symbol.toStringTag,{value:"Module"}),Object.defineProperty(e,"__esModule",{value:!0})},i.j=364,i.p="https://js-agent.newrelic.com/",(()=>{var e={364:0,953:0};i.f.j=(t,r)=>{var n=i.o(e,t)?e[t]:void 0;if(0!==n)if(n)r.push(n[2]);else{var o=new Promise(((r,i)=>n=e[t]=[r,i]));r.push(n[2]=o);var a=i.p+i.u(t),s=new Error;i.l(a,(r=>{if(i.o(e,t)&&(0!==(n=e[t])&&(e[t]=void 0),n)){var o=r&&("load"===r.type?"missing":r.type),a=r&&r.target&&r.target.src;s.message="Loading chunk "+t+" failed.\n("+o+": "+a+")",s.name="ChunkLoadError",s.type=o,s.request=a,n[1](s)}}),"chunk-"+t,t)}};var t=(t,r)=>{var n,o,[a,s,c]=r,u=0;if(a.some((t=>0!==e[t]))){for(n in s)i.o(s,n)&&(i.m[n]=s[n]);if(c)c(i)}for(t&&t(r);u {i.r(o);var e=i(3325),t=i(5763);const r=Object.values(e.D);function n(e){const n={};return r.forEach((r=>{n[r]=function(e,r){return!1!==(0,t.Mt)(r,"".concat(e,".enabled"))}(r,e)})),n}var a=i(9144);var s=i(5546),c=i(385),u=i(8e3),d=i(5938),f=i(3960),l=i(50);class h extends d.W{constructor(e,t,r){let n=!(arguments.length>3&&void 0!==arguments[3])||arguments[3];super(e,t,r),this.auto=n,this.abortHandler,this.featAggregate,this.onAggregateImported,n&&(0,u.R)(e,r)}importAggregator(){let e=arguments.length>0&&void 0!==arguments[0]?arguments[0]:{};if(this.featAggregate||!this.auto)return;const r=c.il&&!0===(0,t.Mt)(this.agentIdentifier,"privacy.cookies_enabled");let n;this.onAggregateImported=new Promise((e=>{n=e}));const o=async()=>{let t;try{if(r){const{setupAgentSession:e}=await Promise.all([i.e(860),i.e(242)]).then(i.bind(i,3228));t=e(this.agentIdentifier)}}catch(e){(0,l.Z)("A problem occurred when starting up session manager. This page will not start or extend any session.",e)}try{if(!this.shouldImportAgg(this.featureName,t))return void(0,u.L)(this.agentIdentifier,this.featureName);const{lazyFeatureLoader:r}=await i.e(412).then(i.bind(i,8582)),{Aggregate:o}=await r(this.featureName,"aggregate");this.featAggregate=new o(this.agentIdentifier,this.aggregator,e),n(!0)}catch(e){(0,l.Z)("Downloading and initializing ".concat(this.featureName," failed..."),e),this.abortHandler?.(),n(!1)}};c.il?(0,f.b)((()=>o()),!0):o()}shouldImportAgg(r,n){return r!==e.D.sessionReplay||!1!==(0,t.Mt)(this.agentIdentifier,"session_trace.enabled")&&(!!n?.isNew||!!n?.state.sessionReplay)}}var g=i(7633),p=i(7894);class m extends h{static featureName=g.t9;constructor(r,n){let i=!(arguments.length>2&&void 0!==arguments[2])||arguments[2];if(super(r,n,g.t9,i),("undefined"==typeof PerformanceNavigationTiming||c.Tt)&&"undefined"!=typeof PerformanceTiming){const n=(0,t.OP)(r);n[g.Dz]=Math.max(Date.now()-n.offset,0),(0,f.K)((()=>n[g.qw]=Math.max((0,p.z)()-n[g.Dz],0))),(0,f.b)((()=>{const t=(0,p.z)();n[g.OJ]=Math.max(t-n[g.Dz],0),(0,s.p)("timing",["load",t],void 0,e.D.pageViewTiming,this.ee)}))}this.importAggregator()}}var v=i(1117),b=i(1284);class y extends v.w{constructor(e){super(e),this.aggregatedData={}}store(e,t,r,n,i){var o=this.getBucket(e,t,r,i);return o.metrics=function(e,t){t||(t={count:0});return t.count+=1,(0,b.D)(e,(function(e,r){t[e]=w(r,t[e])})),t}(n,o.metrics),o}merge(e,t,r,n,i){var o=this.getBucket(e,t,n,i);if(o.metrics){var a=o.metrics;a.count+=r.count,(0,b.D)(r,(function(e,t){if("count"!==e){var n=a[e],i=r[e];i&&!i.c?a[e]=w(i.t,n):a[e]=function(e,t){if(!t)return e;t.c||(t=x(t.t));return t.min=Math.min(e.min,t.min),t.max=Math.max(e.max,t.max),t.t+=e.t,t.sos+=e.sos,t.c+=e.c,t}(i,a[e])}}))}else o.metrics=r}storeMetric(e,t,r,n){var i=this.getBucket(e,t,r);return i.stats=w(n,i.stats),i}getBucket(e,t,r,n){this.aggregatedData[e]||(this.aggregatedData[e]={});var i=this.aggregatedData[e][t];return i||(i=this.aggregatedData[e][t]={params:r||{}},n&&(i.custom=n)),i}get(e,t){return t?this.aggregatedData[e]&&this.aggregatedData[e][t]:this.aggregatedData[e]}take(e){for(var t={},r="",n=!1,i=0;i t.max&&(t.max=e),e 2&&void 0!==arguments[2])||arguments[2];super(e,r,j.t,n),c.il&&((0,t.OP)(e).initHidden=Boolean("hidden"===document.visibilityState),(0,N.N)((()=>(0,s.p)("docHidden",[(0,p.z)()],void 0,j.t,this.ee)),!0),(0,O.bP)("pagehide",(()=>(0,s.p)("winPagehide",[(0,p.z)()],void 0,j.t,this.ee))),this.importAggregator())}}var P=i(3081);class C extends h{static featureName=P.t9;constructor(e,t){let r=!(arguments.length>2&&void 0!==arguments[2])||arguments[2];super(e,t,P.t9,r),this.importAggregator()}}var R,I=i(2210),k=i(1214),H=i(2177),L={};try{R=localStorage.getItem("__nr_flags").split(","),console&&"function"==typeof console.log&&(L.console=!0,-1!==R.indexOf("dev")&&(L.dev=!0),-1!==R.indexOf("nr_dev")&&(L.nrDev=!0))}catch(e){}function z(e){try{L.console&&z(e)}catch(e){}}L.nrDev&&H.ee.on("internal-error",(function(e){z(e.stack)})),L.dev&&H.ee.on("fn-err",(function(e,t,r){z(r.stack)})),L.dev&&(z("NR AGENT IN DEVELOPMENT MODE"),z("flags: "+(0,b.D)(L,(function(e,t){return e})).join(", ")));var M=i(6660);class B extends h{static featureName=M.t;constructor(r,n){let i=!(arguments.length>2&&void 0!==arguments[2])||arguments[2];super(r,n,M.t,i),this.skipNext=0;try{this.removeOnAbort=new AbortController}catch(e){}const o=this;o.ee.on("fn-start",(function(e,t,r){o.abortHandler&&(o.skipNext+=1)})),o.ee.on("fn-err",(function(t,r,n){o.abortHandler&&!n[M.A]&&((0,I.X)(n,M.A,(function(){return!0})),this.thrown=!0,(0,s.p)("err",[n,(0,p.z)()],void 0,e.D.jserrors,o.ee))})),o.ee.on("fn-end",(function(){o.abortHandler&&!this.thrown&&o.skipNext>0&&(o.skipNext-=1)})),o.ee.on("internal-error",(function(t){(0,s.p)("ierr",[t,(0,p.z)(),!0],void 0,e.D.jserrors,o.ee)})),this.origOnerror=c._A.onerror,c._A.onerror=this.onerrorHandler.bind(this),c._A.addEventListener("unhandledrejection",(t=>{const r=function(e){let t="Unhandled Promise Rejection: ";if(e instanceof Error)try{return e.message=t+e.message,e}catch(t){return e}if(void 0===e)return new Error(t);try{return new Error(t+(0,D.P)(e))}catch(e){return new Error(t)}}(t.reason);(0,s.p)("err",[r,(0,p.z)(),!1,{unhandledPromiseRejection:1}],void 0,e.D.jserrors,this.ee)}),(0,O.m$)(!1,this.removeOnAbort?.signal)),(0,k.gy)(this.ee),(0,k.BV)(this.ee),(0,k.em)(this.ee),(0,t.OP)(r).xhrWrappable&&(0,k.Kf)(this.ee),this.abortHandler=this.#e,this.importAggregator()}#e(){this.removeOnAbort?.abort(),this.abortHandler=void 0}onerrorHandler(t,r,n,i,o){"function"==typeof this.origOnerror&&this.origOnerror(...arguments);try{this.skipNext?this.skipNext-=1:(0,s.p)("err",[o||new F(t,r,n),(0,p.z)()],void 0,e.D.jserrors,this.ee)}catch(t){try{(0,s.p)("ierr",[t,(0,p.z)(),!0],void 0,e.D.jserrors,this.ee)}catch(e){}}return!1}}function F(e,t,r){this.message=e||"Uncaught error with no additional information",this.sourceURL=t,this.line=r}let U=1;const q="nr@id";function G(e){const t=typeof e;return!e||"object"!==t&&"function"!==t?-1:e===c._A?0:(0,I.X)(e,q,(function(){return U++}))}function V(e){if("string"==typeof e&&e.length)return e.length;if("object"==typeof e){if("undefined"!=typeof ArrayBuffer&&e instanceof ArrayBuffer&&e.byteLength)return e.byteLength;if("undefined"!=typeof Blob&&e instanceof Blob&&e.size)return e.size;if(!("undefined"!=typeof FormData&&e instanceof FormData))try{return(0,D.P)(e).length}catch(e){return}}}var X=i(7243);class W{constructor(e){this.agentIdentifier=e,this.generateTracePayload=this.generateTracePayload.bind(this),this.shouldGenerateTrace=this.shouldGenerateTrace.bind(this)}generateTracePayload(e){if(!this.shouldGenerateTrace(e))return null;var r=(0,t.DL)(this.agentIdentifier);if(!r)return null;var n=(r.accountID||"").toString()||null,i=(r.agentID||"").toString()||null,o=(r.trustKey||"").toString()||null;if(!n||!i)return null;var a=(0,_.M)(),s=(0,_.Ht)(),c=Date.now(),u={spanId:a,traceId:s,timestamp:c};return(e.sameOrigin||this.isAllowedOrigin(e)&&this.useTraceContextHeadersForCors())&&(u.traceContextParentHeader=this.generateTraceContextParentHeader(a,s),u.traceContextStateHeader=this.generateTraceContextStateHeader(a,c,n,i,o)),(e.sameOrigin&&!this.excludeNewrelicHeader()||!e.sameOrigin&&this.isAllowedOrigin(e)&&this.useNewrelicHeaderForCors())&&(u.newrelicHeader=this.generateTraceHeader(a,s,c,n,i,o)),u}generateTraceContextParentHeader(e,t){return"00-"+t+"-"+e+"-01"}generateTraceContextStateHeader(e,t,r,n,i){return i+"@nr=0-1-"+r+"-"+n+"-"+e+"----"+t}generateTraceHeader(e,t,r,n,i,o){if(!("function"==typeof c._A?.btoa))return null;var a={v:[0,1],d:{ty:"Browser",ac:n,ap:i,id:e,tr:t,ti:r}};return o&&n!==o&&(a.d.tk=o),btoa((0,D.P)(a))}shouldGenerateTrace(e){return this.isDtEnabled()&&this.isAllowedOrigin(e)}isAllowedOrigin(e){var r=!1,n={};if((0,t.Mt)(this.agentIdentifier,"distributed_tracing")&&(n=(0,t.P_)(this.agentIdentifier).distributed_tracing),e.sameOrigin)r=!0;else if(n.allowed_origins instanceof Array)for(var i=0;i 2&&void 0!==arguments[2])||arguments[2];super(r,n,Z.t,i),(0,t.OP)(r).xhrWrappable&&(this.dt=new W(r),this.handler=(e,t,r,n)=>(0,s.p)(e,t,r,n,this.ee),(0,k.u5)(this.ee),(0,k.Kf)(this.ee),function(r,n,i,o){function a(e){var t=this;t.totalCbs=0,t.called=0,t.cbTime=0,t.end=E,t.ended=!1,t.xhrGuids={},t.lastSize=null,t.loadCaptureCalled=!1,t.params=this.params||{},t.metrics=this.metrics||{},e.addEventListener("load",(function(r){_(t,e)}),(0,O.m$)(!1)),c.IF||e.addEventListener("progress",(function(e){t.lastSize=e.loaded}),(0,O.m$)(!1))}function s(e){this.params={method:e[0]},T(this,e[1]),this.metrics={}}function u(e,n){var i=(0,t.DL)(r);i.xpid&&this.sameOrigin&&n.setRequestHeader("X-NewRelic-ID",i.xpid);var a=o.generateTracePayload(this.parsedOrigin);if(a){var s=!1;a.newrelicHeader&&(n.setRequestHeader("newrelic",a.newrelicHeader),s=!0),a.traceContextParentHeader&&(n.setRequestHeader("traceparent",a.traceContextParentHeader),a.traceContextStateHeader&&n.setRequestHeader("tracestate",a.traceContextStateHeader),s=!0),s&&(this.dt=a)}}function d(e,t){var r=this.metrics,i=e[0],o=this;if(r&&i){var a=V(i);a&&(r.txSize=a)}this.startTime=(0,p.z)(),this.listener=function(e){try{"abort"!==e.type||o.loadCaptureCalled||(o.params.aborted=!0),("load"!==e.type||o.called===o.totalCbs&&(o.onloadCalled||"function"!=typeof t.onload)&&"function"==typeof o.end)&&o.end(t)}catch(e){try{n.emit("internal-error",[e])}catch(e){}}};for(var s=0;s 1?e[1]=i:e.push(i)}else e[0]&&e[0].headers&&s(e[0].headers,n)&&(this.dt=n);function s(e,t){var r=!1;return t.newrelicHeader&&(e.set("newrelic",t.newrelicHeader),r=!0),t.traceContextParentHeader&&(e.set("traceparent",t.traceContextParentHeader),t.traceContextStateHeader&&e.set("tracestate",t.traceContextStateHeader),r=!0),r}}function x(e,t){this.params={},this.metrics={},this.startTime=(0,p.z)(),this.dt=t,e.length>=1&&(this.target=e[0]),e.length>=2&&(this.opts=e[1]);var r,n=this.opts||{},i=this.target;"string"==typeof i?r=i:"object"==typeof i&&i instanceof Y?r=i.url:c._A?.URL&&"object"==typeof i&&i instanceof URL&&(r=i.href),T(this,r);var o=(""+(i&&i instanceof Y&&i.method||n.method||"GET")).toUpperCase();this.params.method=o,this.txSize=V(n.body)||0}function A(t,r){var n;this.endTime=(0,p.z)(),this.params||(this.params={}),this.params.status=r?r.status:0,"string"==typeof this.rxSize&&this.rxSize.length>0&&(n=+this.rxSize);var o={txSize:this.txSize,rxSize:n,duration:(0,p.z)()-this.startTime};i("xhr",[this.params,o,this.startTime,this.endTime,"fetch"],this,e.D.ajax)}function E(t){var r=this.params,n=this.metrics;if(!this.ended){this.ended=!0;for(var o=0;o 2&&void 0!==arguments[2])||arguments[2];super(e,t,we.t,r),this.importAggregator()}}new class{constructor(e){let t=arguments.length>1&&void 0!==arguments[1]?arguments[1]:(0,_.ky)(16);c._A?(this.agentIdentifier=t,this.sharedAggregator=new y({agentIdentifier:this.agentIdentifier}),this.features={},this.desiredFeatures=new Set(e.features||[]),this.desiredFeatures.add(m),Object.assign(this,(0,a.j)(this.agentIdentifier,e,e.loaderType||"agent")),this.start()):(0,l.Z)("Failed to initial the agent. Could not determine the runtime environment.")}get config(){return{info:(0,t.C5)(this.agentIdentifier),init:(0,t.P_)(this.agentIdentifier),loader_config:(0,t.DL)(this.agentIdentifier),runtime:(0,t.OP)(this.agentIdentifier)}}start(){const t="features";try{const r=n(this.agentIdentifier),i=[...this.desiredFeatures];i.sort(((t,r)=>e.p[t.featureName]-e.p[r.featureName])),i.forEach((t=>{if(r[t.featureName]||t.featureName===e.D.pageViewEvent){const n=function(t){switch(t){case e.D.ajax:return[e.D.jserrors];case e.D.sessionTrace:return[e.D.ajax,e.D.pageViewEvent];case e.D.sessionReplay:return[e.D.sessionTrace];case e.D.pageViewTiming:return[e.D.pageViewEvent];default:return[]}}(t.featureName);n.every((e=>r[e]))||(0,l.Z)("".concat(t.featureName," is enabled but one or more dependent features has been disabled (").concat((0,D.P)(n),"). This may cause unintended consequences or missing data...")),this.features[t.featureName]=new t(this.agentIdentifier,this.sharedAggregator)}})),(0,T.Qy)(this.agentIdentifier,this.features,t)}catch(e){(0,l.Z)("Failed to initialize all enabled instrument classes (agent aborted) -",e);for(const e in this.features)this.features[e].abortHandler?.();const r=(0,T.fP)();return delete r.initializedAgents[this.agentIdentifier]?.api,delete r.initializedAgents[this.agentIdentifier]?.[t],delete this.sharedAggregator,r.ee?.abort(),delete r.ee?.get(this.agentIdentifier),!1}}}({features:[J,m,S,class extends h{static featureName=oe;constructor(t,r){if(super(t,r,oe,!(arguments.length>2&&void 0!==arguments[2])||arguments[2]),!c.il)return;const n=this.ee;let i;(0,k.QU)(n),this.eventsEE=(0,k.em)(n),this.eventsEE.on(se,(function(e,t){this.bstStart=(0,p.z)()})),this.eventsEE.on(ae,(function(t,r){(0,s.p)("bst",[t[0],r,this.bstStart,(0,p.z)()],void 0,e.D.sessionTrace,n)})),n.on(ce+ne,(function(e){this.time=(0,p.z)(),this.startPath=location.pathname+location.hash})),n.on(ce+ie,(function(t){(0,s.p)("bstHist",[location.pathname+location.hash,this.startPath,this.time],void 0,e.D.sessionTrace,n)}));try{i=new PerformanceObserver((t=>{const r=t.getEntries();(0,s.p)(te,[r],void 0,e.D.sessionTrace,n)})),i.observe({type:re,buffered:!0})}catch(e){}this.importAggregator({resourceObserver:i})}},C,xe,B,class extends h{static featureName=de;constructor(e,r){if(super(e,r,de,!(arguments.length>2&&void 0!==arguments[2])||arguments[2]),!c.il)return;if(!(0,t.OP)(e).xhrWrappable)return;try{this.removeOnAbort=new AbortController}catch(e){}let n,i=0;const o=this.ee.get("tracer"),a=(0,k._L)(this.ee),s=(0,k.Lg)(this.ee),u=(0,k.BV)(this.ee),d=(0,k.Kf)(this.ee),f=this.ee.get("events"),l=(0,k.u5)(this.ee),h=(0,k.QU)(this.ee),g=(0,k.Gm)(this.ee);function m(e,t){h.emit("newURL",[""+window.location,t])}function v(){i++,n=window.location.hash,this[ve]=(0,p.z)()}function b(){i--,window.location.hash!==n&&m(0,!0);var e=(0,p.z)();this[pe]=~~this[pe]+e-this[ve],this[ye]=e}function y(e,t){e.on(t,(function(){this[t]=(0,p.z)()}))}this.ee.on(ve,v),s.on(be,v),a.on(be,v),this.ee.on(ye,b),s.on(ge,b),a.on(ge,b),this.ee.buffer([ve,ye,"xhr-resolved"],this.featureName),f.buffer([ve],this.featureName),u.buffer(["setTimeout"+le,"clearTimeout"+fe,ve],this.featureName),d.buffer([ve,"new-xhr","send-xhr"+fe],this.featureName),l.buffer([me+fe,me+"-done",me+he+fe,me+he+le],this.featureName),h.buffer(["newURL"],this.featureName),g.buffer([ve],this.featureName),s.buffer(["propagate",be,ge,"executor-err","resolve"+fe],this.featureName),o.buffer([ve,"no-"+ve],this.featureName),a.buffer(["new-jsonp","cb-start","jsonp-error","jsonp-end"],this.featureName),y(l,me+fe),y(l,me+"-done"),y(a,"new-jsonp"),y(a,"jsonp-end"),y(a,"cb-start"),h.on("pushState-end",m),h.on("replaceState-end",m),window.addEventListener("hashchange",m,(0,O.m$)(!0,this.removeOnAbort?.signal)),window.addEventListener("load",m,(0,O.m$)(!0,this.removeOnAbort?.signal)),window.addEventListener("popstate",(function(){m(0,i>1)}),(0,O.m$)(!0,this.removeOnAbort?.signal)),this.abortHandler=this.#e,this.importAggregator()}#e(){this.removeOnAbort?.abort(),this.abortHandler=void 0}}],loaderType:"spa"})})(),window.NRBA=o})(); window.jQuery || document.write(' ') CKEDITOR_BASEPATH='https://f1000research.com/js/vendor/ckeditor/' window.reactTheme = 'research'; window.MathJax = { CommonHTML: { linebreaks: { automatic: true } }, 'HTML-CSS': { linebreaks: { automatic: true } }, SVG: { linebreaks: { automatic: true } }, AuthorInit: function() { MathJax.Hub.Register.MessageHook('End Process', function () { let timeout = false; // holder for timeout id const delay = 250; // delay after event is "complete" to run callback const reflowMath = function() { const dispFormulas = document.querySelectorAll('.disp-formula.panel'); if (!dispFormulas) { return; } for (const dispFormula of dispFormulas) { const child = dispFormula.querySelector('.MathJax_Preview').nextSibling.firstChild; const isMultiline = MathJax.Hub.getAllJax(dispFormula)[0].root.isMultiline; if (dispFormula.offsetWidth < child.offsetWidth || isMultiline) { MathJax.Hub.Queue(['Rerender', MathJax.Hub, dispFormula]); } } }; window.addEventListener('resize', function() { clearTimeout(timeout); // clear the timeout timeout = setTimeout(reflowMath, delay); // start timing for event "completion" }); }); }, }; if (window.location.hash == '#_=_'){ window.location = window.location.href.split('#')[0] } !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function() {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)} ;if(!f._fbq)f._fbq=n; n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0; t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window, document,'script','https://connect.facebook.net/en_US/fbevents.js'); fbq('init', '1641728616063202'); fbq('track', "PixelInitialized", {}); (function(h,o,t,j,a,r){ h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)}; h._hjSettings={hjid:2318163,hjsv:6}; a=o.getElementsByTagName('head')[0]; r=o.createElement('script');r.async=1; r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv; a.appendChild(r); })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv='); search file_upload Submit your research search menu close search Browse Gateways & Collections How to Publish Submit your Research My Submissions Article Guidelines Article Guidelines (New Versions) Open Data, Software and Code Guidelines Open Data and Accessible Source Materials Guidelines (HSS) Open Data, Software and Code Guidelines (PSE) Prepublication Checks Production Process Posters and Slides Guidelines Document Guidelines Article Processing Charges Peer Review Finding Article Reviewers About How it Works For Reviewers Our Advisors Policies Glossary FAQs For Developers Newsroom Contact My Research Submissions Content and Tracking Alerts My Details Sign In file_upload Submit your research { "@context": "https://schema.org", "@type": "ScholarlyArticle", "mainEntityOfPage": { "@type": "WebPage", "@id": "https://f1000research.com/articles/10-816" }, "headline": "Left Ventricular Function Recovery After Coronary Revascularization and Medical Therapy: A Systematic Review...", "datePublished": "2021-08-16T16:38:14", "dateModified": "2021-08-16T16:38:14", "author": [ { "@type": "Person", "name": "Janet M.C Ngu" }, { "@type": "Person", "name": "George E. Wharmby" }, { "@type": "Person", "name": "Jillian Rodger" }, { "@type": "Person", "name": "Thin X. Vo" }, { "@type": "Person", "name": "Ming H. Guo" }, { "@type": "Person", "name": "Sarah Visintini" }, { "@type": "Person", "name": "George A. Wells" }, { "@type": "Person", "name": "Alomgir Hossain" }, { "@type": "Person", "name": "Marc Ruel" }, { "@type": "Person", "name": "Rob S. Beanlands" }, { "@type": "Person", "name": "Peter P. Liu" }, { "@type": "Person", "name": "Sylvain Boet" }, { "@type": "Person", "name": "Louise Y. Sun" } ], "publisher": { "@type": "Organization", "name": "F1000Research", "logo": { "@type": "ImageObject", "url": "https://f1000research.com/img/AMP/F1000Research_image.png", "height": 480, "width": 60 } }, "image": { "@type": "ImageObject", "url": "https://f1000research.com/img/AMP/F1000Research_image.png", "height": 1200, "width": 150 }, "description": "Background: The prevalence of coronary artery disease (CAD) with reduced left ventricular ejection fraction (LVEF) is rising, but the optimal treatment remains unclear. The present study aims to investigate the impact of revascularization (coronary artery bypass grafting (CABG), or percutaneous coronary intervention (PCI)) and medical therapy (MT) on LVEF recovery in patients with CAD and LVEF ≤ 40%. Methods: All clinical studies which reported LVEF in patients with CAD and LVEF ≤ 40% undergoing either revascularization or MT were included. A systematic literature search up to May 11, 2017 was performed on MEDLINE, EMBASE and the Cochrane Library in Ovid. Studies were assessed for eligibility and data were extracted by independent reviewers in duplicate with disagreements resolved by a third reviewer. Bias assessment was performed using the Newcastle-Ottawa Scale. Random effect meta-analysis was performed on included studies. The primary outcome was change in LVEF after intervention as compared to baseline. Results: 83 cohort studies with a total of 7,157 patients were included. We observed a statistically significant increase in LVEF following revascularization with CABG (MD 7.76; 95% CI: 6.81 to 8.70; p<0.00001; I2=99%) and PCI (MD 6.70; 95% CI: 4.71 to 8.70; p<0.00001; I2=94%) but not after MT (MD 4.06; 95% CI: -2.12 to 10.24; p=0.20; I2=98%). Conclusion: In patients with CAD and LVEF ≤ 40%, revascularization leads to LVEF recovery as compared to MT. There is continued need for RCT level evidence to enable optimization of treatment selection in this difficult population." } { "@context": "http://schema.org", "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": "1", "item": { "@id": "https://f1000research.com/", "name": "Home" } }, { "@type": "ListItem", "position": "2", "item": { "@id": "https://f1000research.com/browse/articles", "name": "Browse" } }, { "@type": "ListItem", "position": "3", "item": { "@id": "https://f1000research.com/articles/10-816/v1", "name": "Left Ventricular Function Recovery After Coronary Revascularization..." } } ] } Home Browse Left Ventricular Function Recovery After Coronary Revascularization... ALL Metrics - Views Downloads Get PDF Get XML Cite How to cite this article Ngu JMC, Wharmby GE, Rodger J et al. Left Ventricular Function Recovery After Coronary Revascularization and Medical Therapy: A Systematic Review and Meta-Analysis [version 1; peer review: awaiting peer review] . F1000Research 2021, 10 :816 ( https://doi.org/10.12688/f1000research.54766.1 ) NOTE: If applicable, it is important to ensure the information in square brackets after the title is included in all citations of this article. Close Copy Citation Details Export Export Citation Sciwheel EndNote Ref. Manager Bibtex ProCite Sente EXPORT Select a format first Track Share ▬ ✚ Systematic Review Left Ventricular Function Recovery After Coronary Revascularization and Medical Therapy: A Systematic Review and Meta-Analysis [version 1; peer review: awaiting peer review] Janet M.C Ngu https://orcid.org/0000-0002-7313-462X 1 , George E. Wharmby 2 , Jillian Rodger 2 , [...] Thin X. Vo https://orcid.org/0000-0003-3381-3115 1 , Ming H. Guo 1 , Sarah Visintini 3 , George A. Wells 4,5 , Alomgir Hossain 4,5 , Marc Ruel 1 , Rob S. Beanlands 6 , Peter P. Liu 6 , Sylvain Boet 7 , Louise Y. Sun https://orcid.org/0000-0003-3381-3115 2,5,8,9 Janet M.C Ngu https://orcid.org/0000-0002-7313-462X 1 , George E. Wharmby 2 , [...] Jillian Rodger 2 , Thin X. Vo https://orcid.org/0000-0003-3381-3115 1 , Ming H. Guo 1 , Sarah Visintini 3 , George A. Wells 4,5 , Alomgir Hossain 4,5 , Marc Ruel 1 , Rob S. Beanlands 6 , Peter P. Liu 6 , Sylvain Boet 7 , Louise Y. Sun https://orcid.org/0000-0003-3381-3115 2,5,8,9 PUBLISHED 16 Aug 2021 Author details Author details 1 Division of Cardiac Surgery, University of Ottawa Heart Institute, Ottawa, Ontario, K1Y 4W7, Canada 2 Division of Cardiac Anesthesiology, University of Ottawa Heart Institute, Ottawa, ON, K1Y 4W7, Canada 3 Berkman Library, University of Ottawa Heart Institute, Ottawa, Ontario, K1Y 4W7, Canada 4 Cardiovascular Research Methods Centre, University of Ottawa Heart Institute, Ottawa, Ontario, K1Y 4W7, Canada 5 School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, K1G 5Z3, Canada 6 Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, K1Y 4W7, Canada 7 Office of Francophone Affairs, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, K1H 8M5, Canada 8 Department of Anesthesiology and Pain Medicine, The Ottawa Hospital, Ottawa, Ontario, K1Y 4E9, Canada 9 Institute for Clinical Evaluative Sciences, Ottawa, Ontario, M4N 3M5, Canada Janet M.C Ngu Roles: Data Curation, Formal Analysis, Investigation, Project Administration, Visualization, Writing – Original Draft Preparation, Writing – Review & Editing George E. Wharmby Roles: Data Curation, Visualization, Writing – Original Draft Preparation, Writing – Review & Editing Jillian Rodger Roles: Data Curation, Visualization, Writing – Review & Editing Thin X. Vo Roles: Data Curation, Visualization, Writing – Review & Editing Ming H. Guo Roles: Data Curation, Visualization, Writing – Review & Editing Sarah Visintini Roles: Methodology, Validation, Visualization, Writing – Review & Editing George A. Wells Roles: Formal Analysis, Investigation, Methodology, Validation, Visualization, Writing – Review & Editing Alomgir Hossain Roles: Formal Analysis, Investigation, Visualization, Writing – Review & Editing Marc Ruel Roles: Visualization, Writing – Review & Editing Rob S. Beanlands Roles: Visualization, Writing – Review & Editing Peter P. Liu Roles: Visualization, Writing – Review & Editing Sylvain Boet Roles: Visualization, Writing – Review & Editing Louise Y. Sun Roles: Conceptualization, Data Curation, Formal Analysis, Funding Acquisition, Investigation, Methodology, Project Administration, Resources, Supervision, Validation, Visualization, Writing – Original Draft Preparation, Writing – Review & Editing OPEN PEER REVIEW REVIEWER STATUS AWAITING PEER REVIEW Abstract Background: The prevalence of coronary artery disease (CAD) with reduced left ventricular ejection fraction (LVEF) is rising, but the optimal treatment remains unclear. The present study aims to investigate the impact of revascularization (coronary artery bypass grafting (CABG), or percutaneous coronary intervention (PCI)) and medical therapy (MT) on LVEF recovery in patients with CAD and LVEF ≤ 40%. Methods: All clinical studies which reported LVEF in patients with CAD and LVEF ≤ 40% undergoing either revascularization or MT were included. A systematic literature search up to May 11, 2017 was performed on MEDLINE, EMBASE and the Cochrane Library in Ovid. Studies were assessed for eligibility and data were extracted by independent reviewers in duplicate with disagreements resolved by a third reviewer. Bias assessment was performed using the Newcastle-Ottawa Scale. Random effect meta-analysis was performed on included studies. The primary outcome was change in LVEF after intervention as compared to baseline. Results: 83 cohort studies with a total of 7,157 patients were included. We observed a statistically significant increase in LVEF following revascularization with CABG (MD 7.76; 95% CI: 6.81 to 8.70; p<0.00001; I 2 =99%) and PCI (MD 6.70; 95% CI: 4.71 to 8.70; p<0.00001; I 2 =94%) but not after MT (MD 4.06; 95% CI: -2.12 to 10.24; p=0.20; I 2 =98%). Conclusion: In patients with CAD and LVEF ≤ 40%, revascularization leads to LVEF recovery as compared to MT. There is continued need for RCT level evidence to enable optimization of treatment selection in this difficult population. READ ALL READ LESS Keywords Coronary artery disease; Left ventricular ejection fraction; coronary artery bypass grafting; per-cutaneous coronary intervention; medical therapy Corresponding Author(s) Louise Y. Sun ( [email protected] ) Close Corresponding author: Louise Y. Sun Competing interests: No competing interests were disclosed. Grant information: Dr. Beanlands is supported the endowed Vered Chair at the University of Ottawa Heart Institute and a Tier 1 Canada Research Chair in Cardiovascular Disease. Dr. Ruel is supported by the endowed M. Pitfield cardiac surgery research chair at the University of Ottawa Heart Institute. Dr. Boet is supported by The Ottawa Hospital Anesthesia Alternate Funds Association and the Faculty of Medicine, University of Ottawa with a Tier 2 Clinical Research Chair. Dr. Sun is supported by a Tier 2 Clinical Research Chair in Big Data and Cardiovascular Outcomes at the University of Ottawa and the Ottawa Heart Institute Research Corporation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Copyright: © 2021 Ngu JMC et al . This is an open access article distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. How to cite: Ngu JMC, Wharmby GE, Rodger J et al. Left Ventricular Function Recovery After Coronary Revascularization and Medical Therapy: A Systematic Review and Meta-Analysis [version 1; peer review: awaiting peer review] . F1000Research 2021, 10 :816 ( https://doi.org/10.12688/f1000research.54766.1 ) First published: 16 Aug 2021, 10 :816 ( https://doi.org/10.12688/f1000research.54766.1 ) Latest published: 16 Aug 2021, 10 :816 ( https://doi.org/10.12688/f1000research.54766.1 ) Introduction The prevalence of heart failure is rising, and ischemic cardiomyopathy is currently the most common cause. 1 , 2 Ischemic cardiomyopathy is commonly defined as left ventricular (LV) ejection fraction (EF) of 40% or less in the context of coronary artery disease (CAD) as evidenced by angiographic diagnosis, a history of myocardial infarction, or prior revascularization. There is evidence that patients with recovered EF, either by natural history or in response to therapy, 3 have distinctly better 3-year survival and fewer cardiovascular and HF-related hospitalizations. 4 However, LVEF recovery has not been the primary subject of investigation in randomized clinical trials (RCTs). 5 , 6 The Surgical Treatment for Ischemic Heart Failure Extension Study (STICHES) demonstrated at a decade of follow-up, that CABG plus standard medical therapy (MT) for ischemic cardiomyopathy resulted in lower rates of all-cause mortality and hospitalization than those who received MT alone. 6 However, LVEF recovery was not specifically studied. Indeed, the vast majority of revascularization trials have excluded patients with reduced LVEF. In the ARTS, MASS II, SoS, CARDia, SYNTAX and FREEDOM trials, the mean LVEF before intervention was between 57-67%. 7 – 12 We conducted a systematic review of the literature and analyzed all available evidence to date from both randomized and observational studies evaluating the impact of CABG, percutaneous coronary intervention (PCI), and MT on LVEF recovery in patients with ischemic cardiomyopathy. Methods Data sources and search strategy This study was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement for conducting systematic reviews and meta-analyses in healthcare interventions. 13 A literature search strategy was created by a medical librarian (SV) using a combination of keywords and subject headings relating to heart failure, revascularization and reduced ejection fraction, 14 and was peer reviewed by another according to the PRESS guideline. 15 The MEDLINE line search strategy is shown in Supplemental Table 1 in the data availability section. We systematically searched MEDLINE, EMBASE and the Cochrane Library in Ovid from inception until May 11 th , 2017. We also searched the reference list of landmark papers for additional relevant studies. The review protocol was registered in PROSPERO (CRD42017069849). Selection criteria and outcomes measures This study was designed to examine the degree of change in LVEF after CABG, PCI and MT in adult patients with CAD and LVEF < 40%. All full text, randomized, and comparative or single arm observational studies published in the English language were eligible for inclusion. Editorial letters, conference presentations, or non-original studies were excluded. We also excluded studies without a documented LVEF prior to intervention, of patients with non-ischemic cardiomyopathy, a history of cardiac resynchronization therapy or previous revascularization procedure, underwent CABG with concomitant valvular procedure, LV remodeling or ventricular assist device surgery, received stem cell therapy or intracoronary medications. Our outcome of interest was the difference in LVEF after intervention as compared to baseline. For patients with multiple LVEF measurements, the last value reported was used for analysis. Data abstraction and quality assessment Two independent reviewers (G.E.W. & T.X.V.) assessed each reference against eligibility criteria, and a third reviewer (J.M.C.N.) resolved conflicts. The same process applied when extracting data into pre-specified forms. Bias assessment was performed using the Newcastle-Ottawa Scale. 16 We performed sensitivity analyses to account for emerging biases. Statistical analysis Random effects meta-analysis was undertaken using Review Manager version 5.3 (Cochrane Collaboration). Mean differences were used to pool continuous outcomes. Weighted mean differences were calculated using the inverse variance method. For studies in which mean and standard deviation were not provided, we estimated them using the median and range, as described previously. 17 We reported heterogeneity as low ( I 2 = 0% to 25%), moderate ( I 2 = 26% to 50%), and high ( I 2 > 50%). 18 We also conducted subgroup analyses according to the year of publication, timing of follow-up, baseline LVEF and the presence of viability testing. Furthermore, we tested the interaction between baseline LVEF and timing of follow-up. All results were reported as pooled weighted results with 95% confidence interval (CI), with statistical significance defined as a two-tailed p-value of less than 0.05. Results Study selection and patient characteristics Our literature searches identified a total of 5992 references. The PRISMA flow chart is illustrated in Figure 1 . After title and abstract screening, 5063 studies were excluded, leaving 640 studies for full text screening. Detailed review of these articles led to the exclusion of 557 studies, leaving 83 studies including 6 double-arm and 77 single-arm studies (69 on CABG; 4 on PCI; 4 on MT) available for data extraction ( Figure 1 ). The characteristics of the included studies were summarized in Supplemental Table 2 in the data availability section. Baseline patient characteristics are shown in Supplemental Table 3. Of a total of 7,157 patients, 6,061 underwent CABG, 747 underwent PCI, and 349 received MT. Myocardial viability testing was performed in 58% (48/83) of the studies. Of these included studies, 73 were rated as poor, 9 as fair and 1 as good quality using the New-Castle Ottawa Scale (Supplemental Table 4 in the data availability section). Figure 1. PRISMA flow diagram. Abbreviations : RCT = randomized controlled trial; CABG = coronary artery bypass grafting; MT = medical therapy; PCI = percutaneous coronary intervention. LVEF recovery after CABG, PCI, or MT Table 1 summarizes the mean difference (MD) in LVEF following different therapeutic approaches in patients with ischemic cardiomyopathy. The MD was calculated as LVEF after – LVEF before intervention. Figure 2 shows the forest plot of LVEF change in CABG, PCI and MT groups. Seventy-five studies reported changes in LVEF following CABG in 6,061 patients. There was a statistically significant increase in LVEF following CABG (MD 7.76; 95% CI: 6.81 to 8.70; p < 0.0001; I 2 = 99%). Six studies reported LVEF recovery following PCI in 747 patients. A statistically significant increase in LVEF was found following PCI (MD 6.70; 95% CI: 4.71 to 8.70; p < 0.0001; I 2 = 94%). Seven studies reported LVEF after MT in 349 patients. There was no statistically significant change in LVEF following MT (MD 4.06; 95% CI: −2.12 to 10.24; p = 0.20; I 2 = 98%). Figure 2. Forest plot of LVEF change in CABG, PCI and MT groups. Table 1. Summary of mean difference in LVEF following CABG, PCI, or medical therapy. Treatment Groups Studies Participants Statistical Method Effect Estimate Medical Therapy 7 349 Mean Difference ( ‡ IV, Random, 95% § CI) 4.06 [-2.12, 10.24] * PCI 6 747 Mean Difference (IV, Random, 95% CI) 6.70 [4.71, 8.70] † CABG 75 6061 Mean Difference (IV, Random, 95% CI) 7.76 [6.81, 8.70] * PCI = percutaneous coronary intervention. † CABG = coronary artery bypass grafting. ‡ IV = inverse variance. § CI = confidence interval. Sensitivity analyses We conducted several post-hoc subgroup analyses to account for the heterogeneity of the included CABG studies. Subgroup analyses were not feasible for PCI and MT, given the limited number of articles available. By publication date The included CABG studies ranged between 1980-2017. We stratified these studies as before 2000, 2000-2010 and after 2010 to account for improvements in surgical techniques and perioperative care over time. Overall, the MD in LVEF decreased over time while remaining statistically significant ( Table 2 ). Table 2. Mean difference in LVEF following CABG, by year of publication (before 2000, 2000-2010, and after 2010). Year of Publication Studies Statistical Method Effect Estimate Before 2000 22 Mean Difference ( * IV, Random, 95% † CI) 9.36 [6.74, 11.99] 2000 – 2010 42 Mean Difference (IV, Random, 95% CI) 7.30 [6.02, 8.57] After 2010 12 Mean Difference (IV, Random, 95% CI) 6.47 [4.00, 8.93] * IV = inverse variance. † CI = confidence interval. By timing of follow-up We stratified the CABG studies by the time period during which follow-up assessment of LV function was performed (immediately postoperatively, at 0-3 months, 3-6 months, 6-12 months and > 1 year) ( Table 3 ). The magnitude of LVEF improvement was greatest during the first 3 months of follow-up. No obvious LVEF recovery trends were observed during the follow-up period. Table 3. Mean difference in LVEF following CABG over different timings of follow-up. Timing of Follow-up Studies Statistical Method Effect Estimate Immediate Postop 8 Mean Difference ( * IV, Random, 95% † CI) 7.09 [4.48, 9.69] 0 – 3 Months 19 Mean Difference (IV, Random, 95% CI) 8.51 [6.08, 10.93] 3 – 6 Months 14 Mean Difference (IV, Random, 95% CI) 7.68 [5.07, 10.29] 6 – 12 Months 24 Mean Difference (IV, Random, 95% CI) 7.59 [6.05, 9.13] Beyond 1 Year 20 Mean Difference (IV, Random, 95% CI) 7.41 [4.77, 10.04] * IV = inverse variance. † CI = confidence interval. By baseline LVEF We stratified the studies by baseline LVEF of < 30% and ≥ 30% ( Table 4 ) and observed a numerically higher increase in LVEF in patients whose baseline function was < 30% (MD 8.41; 95% CI: 7.19 to 9.63; p < 0.00001; I 2 = 99%) as compared to those whose baseline LVEF was ≥ 30% (MD 5.92; 95% CI: 4.56 to 7.29; p < 0.00001; I 2 = 98%). Table 4. Mean difference in LVEF following CABG with a baseline LVEF less than 30% vs. ≥ 30%. Baseline LVEF Studies Statistical Method Effect Estimate <30% 51 Mean Difference ( * IV, Random, 95% † CI) 8.41 [7.19, 9.63] ≥30% 25 Mean Difference (IV, Random, 95% CI) 5.92 [4.56, 7.29] * IV = inverse variance. † CI = confidence interval. By baseline LVEF And timing of follow-up In the immediate postoperative period, we observed a numerically higher magnitude of LVEF improvement in patients whose baseline function were ≥ 30% (MD 7.22; 95% CI: 1.33 to 13.11; p < 0.00001; I 2 = 100% vs. MD 7.01; 95% CI: 3.59 to 10.43; p < 0.00001; I 2 = 100%). However, at other intervals of follow-up, those with a baseline LVEF of < 30% showed greater improvement in LVEF ( Table 5 ). Table 5. Mean difference in LVEF following CABG as analyzed by baseline LVEF (less than 30% vs. ≥ 30%) and time out from surgery. Time of Follow-up Studies Statistical Method Effect estimate Immediate Postop * LVEF < 30% LVEF ≥ 30% 5 3 Mean Difference ( † IV, Random, 95% ‡ CI) Mean Difference (IV, Random, 95% CI) 7.01 [3.59, 10.43] 7.22 [1.33, 13.11] 0 – 3 months LVEF < 30% LVEF ≥ 30% 14 5 Mean Difference (IV, Random, 95% CI) Mean Difference (IV, Random, 95% CI) 8.74 [5.75, 11.73] 7.52 [3.97, 11.07] 3 – 6 months LVEF < 30% LVEF ≥ 30% 15 6 Mean Difference (IV, Random, 95% CI) Mean Difference (IV, Random, 95% CI) 9.35 [6.75, 11.95] 4.38 [1.02, 7.75] 6 – 12 months LVEF < 30% LVEF ≥ 30% 10 9 Mean Difference (IV, Random, 95% CI) Mean Difference (IV, Random, 95% CI) 7.04 [4.55, 9.54] 6.60 [3.75, 9.46] Beyond 1 year LVEF < 30% LVEF ≥ 30% 13 7 Mean Difference (IV, Random, 95% CI) Mean Difference (IV, Random, 95% CI) 9.26 [5.67, 12.84] 4.08 [2.14, 6.02] * LVEF = left ventricular ejection fraction. † IV = inverse variance. ‡ CI = confidence interval. By the presence of baseline viability testing We stratified the CABG studies based on whether or not viability testing was performed ( Table 6 ). A numerically greater magnitude of improvement in LVEF was observed in the absence of viability testing (MD 10.21; 95% CI: 8.42 to 12.00; p < 0.00001; I 2 = 99% vs. MD 6.42; 95% CI: 5.25 to 7.59; p < 0.0001; I 2 = 99%). Table 6. Mean difference in LVEF following CABG with and without pre-operative myocardial viability testing. Abbreviations: IV = inverse variance; CI = confidence interval. Viability Test Studies Statistical Method Effect Estimate With Viability Test 51 Mean Difference (IV, Random, 95% CI) 6.42 [5.25, 7.59] Without Viability Test 26 Mean Difference (IV, Random, 95% CI) 10.21 [8.42, 12.00] Discussion The current meta-analysis contributes to the literature by comprehensively examining the extent of LVEF recovery following revascularization and MT in patients with CAD and reduced LVEF. We observed an improvement in LVEF after revascularization by CABG or PCI but not with MT alone, and that CABG was associated with a numerically greater magnitude of LVEF improvement as compared to PCI and MT. We demonstrated that revascularization in the setting of CAD and severely reduced LVEF resulted in some degree of LVEF recovery. This observation could be physiologically explained by the restoration of blood flow to malperfused myocardium, which cannot be achieved with MT alone. 19 Nonetheless, guideline-directed MT is associated with survival benefit in patients with CAD and reduced LVEF 20 – 24 and should be prescribed in this patient group for that reason. 25 The improvement in LVEF was numerically highest in patients who underwent CABG. This observation could be attributed to more frequent complete revascularization with CABG, as well as a higher likelihood of long-term patency of CABG grafts as compared to stents. 26 Several trials have noted a greater need for repeat revascularization after PCI as compared to CABG, as well as a higher rate of adverse cardiovascular events; all of which may negate the left ventricular recovery process. 27 – 30 In contrast, the creation of an epicardial conduit bypasses the culprit lesion and additional vulnerable plaques, reduces the likelihood of future cardiac events, and mechanistically optimizes LVEF recovery. 31 This is especially important in the setting of ischemic cardiomyopathy, where the burden of coronary lesions is diffuse and anatomically complex; making complete revascularization and graft longevity more feasible with CABG. 32 , 33 One must also consider the alternate explanation that studies of CABG and/or PCI may be confounded by selection bias, whereby patients who were deemed more likely to derive long-term benefits from revascularization were preferentially selected for these procedures over MT. This highlights the need for a randomized clinical trial to directly compare revascularization vs. MT, to determine the long-term efficacy of each strategy in terms of LVEF recovery. A greater degree of LVEF recovery was observed following CABG in patients without preoperative viability testing. It is important to recognize that viability testing is not routinely performed in all patients with ischemic heart disease and it would usually be done in patients with less certainty of recovery. In the context of ischemic cardiomyopathy, the loss of LV contractile function occurs as a consequence of myocardial necrosis, scarring, stunning, or myocardial hibernation. Myocardial stunning results from brief ischemic insults and manifests as a reversible reduction in contractile function after flow is restored, whereas hibernating myocardium refers to viable but non-functioning myocardium that likely results from down-regulation of ventricular function thought to occur after repetitive ischemia and stunning. Perfusion is often observed to be reduced which may also be a down-regulation. 34 Traditionally, both stunned and hibernating myocardium are regarded as important functional reservoirs with the potential to recover after restoration of blood flow by revascularization. 35 , 36 It is this rationale that has driven the investigation of viability testing to predict the extent of LVEF recovery after revascularization. 36 – 38 Interestingly, a recent study found no association between the amount of hibernating myocardium and LVEF recovery following CABG. 39 The authors posit that chronic, severe reduction in coronary flow may reduce the likelihood of LVEF recovery even after restoration of flow. In addition, it is recognized the hibernating myocardium may take several months to a year to recover, and the long-term benefits of revascularization in the context of hibernating myocardium may be attributed to a reduction in arrhythmia, independent of LVEF recovery. A secondary analysis of STICH trial data revealed that CABG had outcome benefit in the presence of proven myocardial viability, however there was no interaction between viability and treatment modality (CABG vs. MT) for the outcome of mortality. 19 Therefore no conclusion could be drawn regarding the utility of viability testing, and its prognostic relevance remains uncertain. 30 Alternatively, studies such as PARR2, showed a trend towards less cardiac death, myocardial infarction or cardiac rehospitalization with viability directed therapy in post-hoc analysis of patients whose treatment adhered to viability imaging recommendations 40 , 41 ; as well as at experienced centers under a team based approach. 42 Our observed lack of LVEF recovery in patients who underwent viability testing may in part be explained by the more prevalent use of this test in cases where treatment decision-making is difficult. In addition, the lack of clear viability cut-off values to guide revascularization decisions poses further limitations on this strategy. In addition to potential survival benefit, LVEF recovery may also be associated with improved quality of life after CABG. Future revascularization trials could be designed to assess the impact of revascularization versus MT on LVEF recovery, as well as to explore the relationship between LVEF recovery and patient-oriented outcomes such as quality of life and disability-free survival. 43 Limitations The data available for the meta-analysis was derived solely from observational studies, as no RCTs met the inclusion criteria. In addition, large variations in patient demographics, regional differences in revascularization versus MT practices and outcomes, and the lack of standardization in the timing of follow-up LVEF assessments, as well as heterogeneity in LVEF assessment modality, likely contributed to the high degree of heterogeneity observed in the analysis. Lastly, the lack of comparative studies precluded comparative meta-analysis. Conclusions In this meta-analysis of studies of patients with CAD and LVEF ≤ 40%, revascularization by PCI or CABG was associated with a greater magnitude of LVEF recovery as compared to MT. There is continued need for RCT level evidence to elucidate the comparative effectiveness of revascularization versus medical therapy and to determine the clinical significance of LVEF recovery in this high-risk patient group. Data availability Open Science Framework. Left ventricular function recovery after coronary revascularization and medical therapy: a systematic review and meta-Analysis. DOI: https://doi.org/10.17605/OSF.IO/HCPT5 . 44 Data are available under the terms of the Creative Commons Attribution 4.0 International license (CC-BY 4.0). References 1. Moran AE, Forouzanfar MH, Roth GA, et al. : The global burden of ischemic heart disease in 1990 and 2010: the Global Burden of Disease 2010 study. Circulation. 2014; 129 : 1493–1501. PubMed Abstract | Publisher Full Text | Free Full Text 2. Felker GM, Shaw LK, O’Connor CM: A standardized definition of ischemic cardiomyopathy for use in clinical research. J Am Coll Cardiol. 2002; 39 : 210–218. PubMed Abstract | Publisher Full Text 3. Agra Bermejo R, Gonzalez Babarro E, Lopez Canoa JN, et al. : Heart failure with recovered ejection fraction: Clinical characteristics, determinants and prognosis. CARDIOCHUS-CHOP registry. Cardiol J. 2018; 25 : 353–362. PubMed Abstract | Publisher Full Text 4. Kalogeropoulos AP, Fonarow GC, Georgiopoulou V, et al. : Characteristics and Outcomes of Adult Outpatients With Heart Failure and Improved or Recovered Ejection Fraction. JAMA Cardiol. 2016; 1 : 510–518. PubMed Abstract | Publisher Full Text 5. Velazquez EJ, Lee KL, Jones RH, et al. : Coronary-Artery Bypass Surgery in Patients with Ischemic Cardiomyopathy. N Engl J Med. 2016; 374 : 1511–1520. PubMed Abstract | Publisher Full Text | Free Full Text 6. Ngu JMC, Ruel M, Sun LY: Left ventricular function recovery after revascularization: comparative effects of percutaneous coronary intervention and coronary artery bypass grafting. Curr Opin Cardiol. 2018; 33 : 633–637. PubMed Abstract | Publisher Full Text 7. Booth J, Clayton T, Pepper J, et al. : Randomized, controlled trial of coronary artery bypass surgery versus percutaneous coronary intervention in patients with multivessel coronary artery disease: six-year follow-up from the Stent or Surgery Trial (SoS). Circulation. 2008; 118 : 381–388. PubMed Abstract | Publisher Full Text 8. Farkouh ME, Domanski M, Sleeper LA, et al. : Strategies for multivessel revascularization in patients with diabetes. N Engl J Med. 2012; 367 : 2375–2384. PubMed Abstract | Publisher Full Text 9. Hueb W, Lopes N, Gersh BJ, et al. : Ten-year follow-up survival of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease. Circulation. 2010; 122 : 949–957. PubMed Abstract | Publisher Full Text 10. Kapur A, Hall RJ, Malik IS, et al. : Randomized comparison of percutaneous coronary intervention with coronary artery bypass grafting in diabetic patients. 1-year results of the CARDia (Coronary Artery Revascularization in Diabetes) trial. J Am Coll Cardiol. 2010; 55 : 432–440. PubMed Abstract | Publisher Full Text 11. Serruys PW, Morice MC, Kappetein AP, et al. : Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med. 2009; 360 : 961–972. PubMed Abstract | Publisher Full Text 12. Serruys PW, Ong AT, van Herwerden LA, et al. : Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: the final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial. J Am Coll Cardiol. 2005; 46 : 575–581. PubMed Abstract | Publisher Full Text 13. Liberati A, Altman DG, Tetzlaff J, et al. : The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol. 2009; 62 : e1–e34. PubMed Abstract | Publisher Full Text 14. Damarell RA, Tieman J, Sladek RM, et al. : Development of a heart failure filter for Medline: an objective approach using evidence-based clinical practice guidelines as an alternative to hand searching. BMC Med Res Methodol. 2011; 11 : 12. PubMed Abstract | Publisher Full Text | Free Full Text 15. McGowan J, Sampson M, Salzwedel DM, et al. : PRESS Peer Review of Electronic Search Strategies: 2015 Guideline Statement. J Clin Epidemiol. 2016; 75 : 40–46. PubMed Abstract | Publisher Full Text 16. Wells GA, Shea B, O”Connell D, et al. : The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomized Studies in Meta-Analyses.2011. 17. Wan X, Wang W, Liu J, et al. : Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. 2014; 14 : 135. PubMed Abstract | Publisher Full Text | Free Full Text 18. Higgins JP, Thompson SG, Deeks JJ, et al. : Measuring inconsistency in meta-analyses. BMJ. 2003; 327 : 557–560. PubMed Abstract | Publisher Full Text | Free Full Text 19. Velazquez EJ, Lee KL, Deja MA, et al. : Coronary-artery bypass surgery in patients with left ventricular dysfunction. N Engl J Med. 2011; 364 : 1607–1616. PubMed Abstract | Publisher Full Text | Free Full Text 20. Garg R, Yusuf S: Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials. JAMA. 1995; 273 : 1450–1456. PubMed Abstract 21. Packer M, Fowler MB, Roecker EB, et al. : Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study. Circulation. 2002; 106 : 2194–2199. PubMed Abstract | Publisher Full Text 22. Committees C-IIa: The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet. 1999; 353 : 9–13. PubMed Abstract 23. Group M-HS: Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet. 1999; 353 : 2001–2007. PubMed Abstract 24. Pitt B, Zannad F, Remme WJ, et al. : The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med. 1999; 341 : 709–717. PubMed Abstract | Publisher Full Text 25. Yancy CW, Jessup M, Bozkurt B, et al. : 2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation. 2013; 128 : 1810–1852. PubMed Abstract | Publisher Full Text 26. Sim I, Gupta M, McDonald K, et al. : A meta-analysis of randomized trials comparing coronary artery bypass grafting with percutaneous transluminal coronary angioplasty in multivessel coronary artery disease. Am J Cardiol. 1995; 76 : 1025–1029. PubMed Abstract | Publisher Full Text 27. Sun LY, Gaudino M, Chen RJ, et al. : Long-term Outcomes in Patients With Severely Reduced Left Ventricular Ejection Fraction Undergoing Percutaneous Coronary Intervention vs Coronary Artery Bypass Grafting. JAMA Cardiol. 2020. PubMed Abstract | Publisher Full Text | Free Full Text 28. Daemen J, Boersma E, Flather M, et al. : Long-term safety and efficacy of percutaneous coronary intervention with stenting and coronary artery bypass surgery for multivessel coronary artery disease: a meta-analysis with 5-year patient-level data from the ARTS, ERACI-II, MASS-II, and SoS trials. Circulation. 2008; 118 : 1146–1154. PubMed Abstract | Publisher Full Text 29. Hage F, Hage A, Haddad H, et al. : Update on revascularization in patients with heart failure and coronary artery disease. Curr Opin Cardiol. 2018; 33 : 232–236. PubMed Abstract | Publisher Full Text 30. Wolff G, Dimitroulis D, Andreotti F, et al. : Survival Benefits of Invasive Versus Conservative Strategies in Heart Failure in Patients With Reduced Ejection Fraction and Coronary Artery Disease: A Meta-Analysis. Circ Heart Fail. 2017; 10 . PubMed Abstract | Publisher Full Text 31. Gersh BJ, Stone GW, Bhatt DL: Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With Left Main and Multivessel Coronary Artery Disease: Do We Have the Evidence? Circulation. 2017; 135 : 819–821. PubMed Abstract | Publisher Full Text 32. Navarese EP, Kowalewski M, Kandzari D, et al. : First-generation versus second-generation drug-eluting stents in current clinical practice: updated evidence from a comprehensive meta-analysis of randomised clinical trials comprising 31 379 patients. Open Heart. 2014; 1 : e000064. PubMed Abstract | Publisher Full Text | Free Full Text 33. Navarese EP, Tandjung K, Claessen B, et al. : Safety and efficacy outcomes of first and second generation durable polymer drug eluting stents and biodegradable polymer biolimus eluting stents in clinical practice: comprehensive network meta-analysis. BMJ. 2013; 347 : f6530. PubMed Abstract | Publisher Full Text | Free Full Text 34. Canty JM Jr, Suzuki G: Myocardial perfusion and contraction in acute ischemia and chronic ischemic heart disease. J Mol Cell Cardiol. 2012; 52 : 822–831. PubMed Abstract | Publisher Full Text | Free Full Text 35. Bonow RO, Maurer G, Lee KL, et al. : Myocardial viability and survival in ischemic left ventricular dysfunction. N Engl J Med. 2011; 364 : 1617–1625. PubMed Abstract | Publisher Full Text | Free Full Text 36. Ling LF, Marwick TH, Flores DR, et al. : Identification of therapeutic benefit from revascularization in patients with left ventricular systolic dysfunction: inducible ischemia versus hibernating myocardium. Circ Cardiovasc Imaging. 2013; 6 : 363–372. PubMed Abstract | Publisher Full Text 37. Allman KC, Shaw LJ, Hachamovitch R, et al. : Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol. 2002; 39 : 1151–1158. PubMed Abstract | Publisher Full Text 38. Panza JA, Holly TA, Asch FM, et al. : Inducible myocardial ischemia and outcomes in patients with coronary artery disease and left ventricular dysfunction. J Am Coll Cardiol. 2013; 61 : 1860–1870. PubMed Abstract | Publisher Full Text | Free Full Text 39. Arora Y, Singh RS, Sampath S, et al. : Impact of hibernating and viable myocardium on improvement in perfusion and left ventricular ejection fraction after coronary artery bypass graft. Nucl Med Commun. 2019; 40 : 325–332. PubMed Abstract | Publisher Full Text 40. Beanlands RS, Nichol G, Huszti E, et al. : F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction and suspected coronary disease: a randomized, controlled trial (PARR-2). J Am Coll Cardiol. 2007; 50 : 2002–2012. PubMed Abstract | Publisher Full Text 41. Mc Ardle B, Shukla T, Nichol G, et al. : Long-Term Follow-Up of Outcomes With F-18-Fluorodeoxyglucose Positron Emission Tomography Imaging-Assisted Management of Patients With Severe Left Ventricular Dysfunction Secondary to Coronary Disease. Circ Cardiovasc Imaging. 2016; 9. PubMed Abstract | Publisher Full Text 42. Abraham A, Nichol G, Williams KA, et al. : 18F-FDG PET imaging of myocardial viability in an experienced center with access to 18F-FDG and integration with clinical management teams: the Ottawa-FIVE substudy of the PARR 2 trial. J Nucl Med. 2010; 51 : 567–574. PubMed Abstract | Publisher Full Text 43. Sun LY, Tu JV, Lee DS, et al. : Disability-free survival after coronary artery bypass grafting in women and men with heart failure. Open Heart. 2018; 5 : e000911. PubMed Abstract | Publisher Full Text | Free Full Text 44. Sun L: Left ventricular function recovery after coronary revascularization and medical therapy: a systematic review and meta-Analysis.2021, July 17. Publisher Full Text Comments on this article Comments (0) Version 1 VERSION 1 PUBLISHED 16 Aug 2021 ADD YOUR COMMENT Comment Author details Author details 1 Division of Cardiac Surgery, University of Ottawa Heart Institute, Ottawa, Ontario, K1Y 4W7, Canada 2 Division of Cardiac Anesthesiology, University of Ottawa Heart Institute, Ottawa, ON, K1Y 4W7, Canada 3 Berkman Library, University of Ottawa Heart Institute, Ottawa, Ontario, K1Y 4W7, Canada 4 Cardiovascular Research Methods Centre, University of Ottawa Heart Institute, Ottawa, Ontario, K1Y 4W7, Canada 5 School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, K1G 5Z3, Canada 6 Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, K1Y 4W7, Canada 7 Office of Francophone Affairs, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, K1H 8M5, Canada 8 Department of Anesthesiology and Pain Medicine, The Ottawa Hospital, Ottawa, Ontario, K1Y 4E9, Canada 9 Institute for Clinical Evaluative Sciences, Ottawa, Ontario, M4N 3M5, Canada Janet M.C Ngu Roles: Data Curation, Formal Analysis, Investigation, Project Administration, Visualization, Writing – Original Draft Preparation, Writing – Review & Editing George E. Wharmby Roles: Data Curation, Visualization, Writing – Original Draft Preparation, Writing – Review & Editing Jillian Rodger Roles: Data Curation, Visualization, Writing – Review & Editing Thin X. Vo Roles: Data Curation, Visualization, Writing – Review & Editing Ming H. Guo Roles: Data Curation, Visualization, Writing – Review & Editing Sarah Visintini Roles: Methodology, Validation, Visualization, Writing – Review & Editing George A. Wells Roles: Formal Analysis, Investigation, Methodology, Validation, Visualization, Writing – Review & Editing Alomgir Hossain Roles: Formal Analysis, Investigation, Visualization, Writing – Review & Editing Marc Ruel Roles: Visualization, Writing – Review & Editing Rob S. Beanlands Roles: Visualization, Writing – Review & Editing Peter P. Liu Roles: Visualization, Writing – Review & Editing Sylvain Boet Roles: Visualization, Writing – Review & Editing Louise Y. Sun Roles: Conceptualization, Data Curation, Formal Analysis, Funding Acquisition, Investigation, Methodology, Project Administration, Resources, Supervision, Validation, Visualization, Writing – Original Draft Preparation, Writing – Review & Editing Competing interests No competing interests were disclosed. Grant information Dr. Beanlands is supported the endowed Vered Chair at the University of Ottawa Heart Institute and a Tier 1 Canada Research Chair in Cardiovascular Disease. Dr. Ruel is supported by the endowed M. Pitfield cardiac surgery research chair at the University of Ottawa Heart Institute. Dr. Boet is supported by The Ottawa Hospital Anesthesia Alternate Funds Association and the Faculty of Medicine, University of Ottawa with a Tier 2 Clinical Research Chair. Dr. Sun is supported by a Tier 2 Clinical Research Chair in Big Data and Cardiovascular Outcomes at the University of Ottawa and the Ottawa Heart Institute Research Corporation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Article Versions (1) version 1 Published: 16 Aug 2021, 10:816 https://doi.org/10.12688/f1000research.54766.1 Copyright © 2021 Ngu JMC et al . This is an open access article distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Download Export To Sciwheel Bibtex EndNote ProCite Ref. Manager (RIS) Sente metrics Views Downloads F1000Research - - PubMed Central info_outline Data from PMC are received and updated monthly. - - Citations open_in_new 0 open_in_new 0 open_in_new SEE MORE DETAILS CITE how to cite this article Ngu JMC, Wharmby GE, Rodger J et al. Left Ventricular Function Recovery After Coronary Revascularization and Medical Therapy: A Systematic Review and Meta-Analysis [version 1; peer review: awaiting peer review] . F1000Research 2021, 10 :816 ( https://doi.org/10.12688/f1000research.54766.1 ) NOTE: If applicable, it is important to ensure the information in square brackets after the title is included in all citations of this article. COPY CITATION DETAILS track receive updates on this article Track an article to receive email alerts on any updates to this article. TRACK THIS ARTICLE Share Open Peer Review Current Reviewer Status: AWAITING PEER REVIEW AWAITING PEER REVIEW ? Key to Reviewer Statuses VIEW HIDE Approved The paper is scientifically sound in its current form and only minor, if any, improvements are suggested Approved with reservations A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. Not approved Fundamental flaws in the paper seriously undermine the findings and conclusions Comments on this article Comments (0) Version 1 VERSION 1 PUBLISHED 16 Aug 2021 ADD YOUR COMMENT Comment keyboard_arrow_left keyboard_arrow_right Open Peer Review Reviewer Status AWAITING PEER REVIEW Comments on this article All Comments (0) Add a comment Sign up for content alerts Sign Up You are now signed up to receive this alert Browse by related subjects Alongside their report, reviewers assign a status to the article: Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions Adjust parameters to alter display View on desktop for interactive features Includes Interactive Elements View on desktop for interactive features Competing Interests Policy Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: Examples of 'Non-Financial Competing Interests' Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper. You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors. You are a close professional associate of any of the authors (e.g. scientific mentor, recent student). You work at the same institute as any of the authors. You hope/expect to benefit (e.g. favour or employment) as a result of your submission. You are an Editor for the journal in which the article is published. Examples of 'Financial Competing Interests' You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements. You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors. You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on. Stay Updated Sign up for content alerts and receive a weekly or monthly email with all newly published articles Register with F1000Research Already registered? Sign in Not now, thanks close PLEASE NOTE If you are an AUTHOR of this article, please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a “User Comment”. If you are a REVIEWER of this article, please check that you have signed in with the account associated with this article and then go to your account to submit your report, please do not post your review here. If you do not have access to your original account, please contact us . All commenters must hold a formal affiliation as per our Policies . The information that you give us will be displayed next to your comment. User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the User Comment Terms and Conditions . Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available. I accept the User Comment Terms and Conditions Please confirm that you accept the User Comment Terms and Conditions. Affiliation ✕ refresh Please enter your institution. Note: To add your institution or organisation, start typing the name and then select the correct name from the list. Where applicable, the name will appear in both the original language and in English. Do not paste in the name. If the name does not appear in the drop-down list, we will display the information you have entered. ✕ refresh Country/Region * USA UK Canada China France Germany Afghanistan Aland Islands Albania Algeria American Samoa Andorra Angola Anguilla Antarctica Antigua and Barbuda Argentina Armenia Aruba Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bosnia and Herzegovina Botswana Bouvet Island Brazil British Indian Ocean Territory British Virgin Islands Brunei Bulgaria Burkina Faso Burundi Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Chad Chile China Christmas Island Cocos (Keeling) Islands Colombia Comoros Congo Cook Islands Costa Rica Cote d'Ivoire Croatia Cuba Cyprus Czech Republic Democratic Republic of the Congo Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Falkland Islands Faroe Islands Federated States of Micronesia Fiji Finland France French Guiana French Polynesia French Southern Territories Gabon Georgia Germany Ghana Gibraltar Greece Greenland Grenada Guadeloupe Guam Guatemala Guernsey Guinea Guinea-Bissau Guyana Haiti Heard Island and Mcdonald Islands Holy See (Vatican City State) Honduras Hong Kong Hungary Iceland India Indonesia Iran Iraq Ireland Israel Italy Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Kosovo (Serbia and Montenegro) Kuwait Kyrgyzstan Lao People's Democratic Republic Latvia Lebanon Lesotho Liberia Libya Liechtenstein Lithuania Luxembourg Macao Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Martinique Mauritania Mauritius Mayotte Mexico Minor Outlying Islands of the United States Moldova Monaco Mongolia Montenegro Montserrat Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands Antilles New Caledonia New Zealand Nicaragua Niger Nigeria Niue Norfolk Island North Korea North Macedonia Northern Mariana Islands Norway Oman Pakistan Palau Palestinian Territory Panama Papua New Guinea Paraguay Peru Philippines Pitcairn Poland Portugal Puerto Rico Qatar Reunion Romania Russian Federation Rwanda Saint Helena Saint Kitts and Nevis Saint Lucia Saint Pierre and Miquelon Saint Vincent and the Grenadines Samoa San Marino Sao Tome and Principe Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia South Africa South Georgia and the South Sandwich Is South Korea South Sudan Spain Sri Lanka Sudan Suriname Svalbard and Jan Mayen Swaziland Sweden Switzerland Syria Taiwan Tajikistan Tanzania Thailand The Gambia The Netherlands Timor-Leste Togo Tokelau Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu UK USA Uganda Ukraine United Arab Emirates United States Virgin Islands Uruguay Uzbekistan Vanuatu Venezuela Vietnam Wallis and Futuna West Bank and Gaza Strip Western Sahara Yemen Zambia Zimbabwe Please select your country/region. You must enter a comment. Competing Interests Please disclose any competing interests that might be construed to influence your judgment of the article's or peer review report's validity or importance. Competing Interests Policy Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: Examples of 'Non-Financial Competing Interests' Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper. You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors. You are a close professional associate of any of the authors (e.g. scientific mentor, recent student). You work at the same institute as any of the authors. You hope/expect to benefit (e.g. favour or employment) as a result of your submission. You are an Editor for the journal in which the article is published. Examples of 'Financial Competing Interests' You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements. You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors. You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on. Please state your competing interests The comment has been saved. An error has occurred. Please try again. Cancel Post var lTitle = "Left Ventricular Function Recovery After...".replace("'", ''); var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/10-816/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by '); var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/10-816/v1&title=" + encodeURIComponent(lTitle); var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/10-816/v1" + "&title=" + encodeURIComponent(lTitle); linkedInUrl += encodeURIComponent('Ngu JMC et al.'); var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; var addthis_config = { ui_offset_top: offsetTop, services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com", services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com", services_custom : [ { name: "LinkedIn", url: linkedInUrl, icon:"/img/icon/at_linkedin.svg" }, { name: "Mendeley", url: "http://www.mendeley.com/import/?url=https://f1000research.com/articles/10-816/v1/mendeley", icon:"/img/icon/at_mendeley.svg" }, { name: "Reddit", url: redditUrl, icon:"/img/icon/at_reddit.svg" }, ] }; var addthis_share = { url: "https://f1000research.com/articles/10-816", templates : { twitter : "Left Ventricular Function Recovery After Coronary Revascularization.... Ngu JMC et al., published by " + "@F1000Research" + ", https://f1000research.com/articles/10-816/v1" } }; if (typeof(addthis) != "undefined"){ addthis.addEventListener('addthis.ready', checkCount); addthis.addEventListener('addthis.menu.share', checkCount); } $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter); $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url); $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url); $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url); $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url); function checkCount(){ setTimeout(function(){ $(".addthis_button_expanded").each(function(){ var count = $(this).text(); if (count !== "" && count != "0") $(this).removeClass("is-hidden"); else $(this).addClass("is-hidden"); }); }, 1000); } close How to cite this report {{reportCitation}} Cancel Copy Citation Details $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');}); $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');}); $.get("/articles/acj/54766/58279") new F1000.Clipboard(); new F1000.ThesaurusTermsDisplay("articles", "article", "58279"); $(document).ready(function() { $( "#frame1" ).on('load', function() { var mydiv = $(this).contents().find("div"); var h = mydiv.height(); console.log(h) }); var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"), titleLivingFigure = tooltipLivingFigure.attr("title"); tooltipLivingFigure.simpletip({ fixed: true, position: ["-115", "30"], baseClass: 'small-tooltip', content:titleLivingFigure + " " }); tooltipLivingFigure.removeAttr("title"); $("body").on("click", ".cite-living-figure", function(e) { e.preventDefault(); var ref = $(this).attr("data-ref"); $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200); }); $("body").on("click", ".close-cite-living-figure", function(e) { e.preventDefault(); $(this).closest(".popup-window-wrapper").fadeOut(200); }); $(document).on("mouseup", function(e) { var metricsContainer = $(".article-metrics-popover-wrapper"); if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) { $(".article-metrics-close-button").click(); } }); var articleId = $('#articleId').val(); if($("#main-article-count-box").attachArticleMetrics) { $("#main-article-count-box").attachArticleMetrics(articleId, { articleMetricsView: true }); } }); var figshareWidget = $(".new_figshare_widget"); if (figshareWidget.length > 0) { window.figshare.load("f1000", function(Widget) { // Select a tag/tags defined in your page. In this tag we will place the widget. _.map(figshareWidget, function(el){ var widget = new Widget({ articleId: $(el).attr("figshare_articleId") //height:300 // this is the height of the viewer part. [Default: 550] }); widget.initialize(); // initialize the widget widget.mount(el); // mount it in a tag that's on your page // this will save the widget on the global scope for later use from // your JS scripts. This line is optional. //window.widget = widget; }); }); } close Error Close Add Reset F1000.MICROSERVICES.AFFILIATION = ''; $(document).ready(function () { $('.js-affiliations-form').each((index, form) => { new AffiliationForm({ formId: form.id, institutionErrorSelector: '.comment-enter-institution', departmentErrorSelector: '.comment-enter-department', placeSelector: '.js-add-comment-place', stateSelector: '.js-add-comment-state', zipCodeSelector: '.js-add-comment-zipcode', countrySelector: '.js-add-comment-country', countryErrorSelector: '.comment-enter-country', }); }); }); $(document).ready(function () { var reportIds = { "100225": 0, "100224": 0, "115231": 0, "266660": 0, "115232": 0, "266661": 0, "266662": 0, "266663": 0, "93861": 0, "266657": 0, "266658": 0, "266659": 0, "307500": 0, "286255": 0, "266664": 0, "266665": 0, "266666": 0, "307499": 0, "286260": 0, "286261": 0, "286262": 0, "286263": 0, "286256": 0, "286257": 0, "286258": 0, "286259": 0, "101561": 0, "101563": 0, "101562": 0, "115389": 0, "101565": 0, "286264": 0, "115388": 0, "101564": 0, "115391": 0, "115390": 0, "256347": 0, "256346": 0, "256351": 0, "128092": 0, "256350": 0, "256349": 0, "256348": 0, "256354": 0, "280933": 0, "123875": 0, "280934": 0, "256352": 0, "123874": 0, "280935": 0, "123877": 0, "256358": 0, "123876": 0, "93414": 0, "256356": 0, "280940": 0, "280941": 0, "280942": 0, "96106": 0, "280936": 0, "280937": 0, "280938": 0, "280939": 0, "92025": 0, "92024": 0, "92027": 0, "92026": 0, }; $(".referee-response-container,.js-referee-report").each(function(index, el) { var reportId = $(el).attr("data-reportid"), reportCount = reportIds[reportId] || 0; $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount); }); var uuidInput = $("#article_uuid"), oldUUId = uuidInput.val(), newUUId = "622e8af5-dcd6-4d01-a494-42580ec1d248"; uuidInput.val(newUUId); $("a[href*='article_uuid=']").each(function(index, el) { var newHref = $(el).attr("href").replace(oldUUId, newUUId); $(el).attr("href", newHref); }); }); An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing. Browse Gateways Collections How it Works Contact For Developers Cookie Notice Privacy Notice RSS Submit Your Research Follow us © 2012-2026 F1000 Research Ltd. ISSN 2046-1402 | Legal | Partner of Research4Life • CrossRef • ORCID • FAIRSharing R.templateTests.simpleTemplate = R.template(' $text $text $text $text $text '); R.templateTests.runTests(); var F1000platform = new F1000.Platform({ name: "f1000research", displayName: "F1000Research", hostName: "f1000research.com", id: "1", editorialEmail: "[email protected]", infoEmail: "[email protected]", usePmcStats: true }); $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');}); // $(function(){R.ui.dropdowns('.dropdown-for-referees');}); $(document).ready(function () { if ($(".cookie-warning").is(":visible")) { $(".sticky").css("margin-bottom", "35px"); $(".devices").addClass("devices-and-cookie-warning"); } $(".cookie-warning .close-button").click(function (e) { $(".devices").removeClass("devices-and-cookie-warning"); $(".sticky").css("margin-bottom", "0"); }); $("#tweeter-feed .tweet-message").each(function (i, message) { var self = $(message); self.html(linkify(self.html())); }); $(".partner").on("mouseenter mouseleave", function() { $(this).find(".gray-scale, .colour").toggleClass("is-hidden"); }); }); Sign In Remember me Forgotten your password? Sign In Cancel Email or password not correct. Please try again Please wait... $(function(){ // Note: All the setup needs to run against a name attribute and *not* the id due the clonish // nature of facebox... $("a[id=googleSignInButton]").click(function(event){ event.preventDefault(); $("input[id=oAuthSystem]").val("GOOGLE"); $("form[id=oAuthForm]").submit(); }); $("a[id=facebookSignInButton]").click(function(event){ event.preventDefault(); $("input[id=oAuthSystem]").val("FACEBOOK"); $("form[id=oAuthForm]").submit(); }); $("a[id=orcidSignInButton]").click(function(event){ event.preventDefault(); $("input[id=oAuthSystem]").val("ORCID"); $("form[id=oAuthForm]").submit(); }); }); If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password. The email address should be the one you originally registered with F1000. Email address not valid, please try again You registered with F1000 via Google, so we cannot reset your password. To sign in, please click here . If you still need help with your Google account password, please click here . You registered with F1000 via Facebook, so we cannot reset your password. To sign in, please click here . If you still need help with your Facebook account password, please click here . Code not correct, please try again Reset password Cancel Email us for further assistance. Server error, please try again. If your email address is registered with us, we will email you instructions to reset your password. If you think you should have received this email but it has not arrived, please check your spam filters and/or contact for further assistance. Please wait... Register $(document).ready(function () { signIn.createSignInAsRow($("#sign-in-form-gfb-popup")); $(".target-field").each(function () { var uris = $(this).val().split("/"); if (uris.pop() === "login") { $(this).val(uris.toString().replace(",","/")); } }); });